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Abstract: 
 
Ataxia telangiectasia (AT) is a well-characterized neurodegenerative disease resulting 
from a genetic defect in the Atm gene causing an absence or very low expression of the 
ATM protein. As AT patients are prone to the development of insulin resistance and 
atherosclerosis, the aim or the current study was to investigate the importance of the ATM 
protein in the endothelium and its role in the signalling pathways of nitric oxide (NO) 
production. To accomplish this, the first objective was to establish an in-house endothelial 
cell isolation technique harvested from normal and insulin resistant animals. Unfortunately, 
these cultures, although staining positive with an endothelial cell specific stain, were not 
pure enough and did not express endothelial NO synthase (eNOS), the central enzyme in 
NO production. 
The remainder of the study utilized commercial aortic endothelial cells (AECs) and found 
that there was a significant increase in NO production when the ATM protein was inhibited 
by the specific inhibitor, Ku-60019. The beneficial impact of increased NO production 
includes maintaining vascular homeostasis, promoting angiogenesis, initiating DNA repair 
by activating p53 and inhibiting smooth muscle cell proliferation. On the other hand, 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) also generated by 
high levels of NO, can exert both protective and harmful effects. Examples of these include 
cell death due to high concentrations of ROS. However, Ku-60019 did not result in 
increased cell death of AECs.  
We demonstrated for the first time, a relationship between endothelial ATM protein kinase 
and the generation of NO. The signalling pathways involved in NO production and glucose 
utilization form a network of interrelationships. Central to both pathways is the activity of 
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two protein kinases, PKB/Akt and AMPK. Both these kinases are known to phosphorylate 
the eNOS enzyme to produce NO on the one hand and AS160 to induce GLUT 4 
translocation and glucose uptake on the other hand. Activation of the ATM protein is 
postulated to be a prerequisite for PKB/Akt activation and it may also result in activation of 
AMPK. However, using insulin to stimulate ATM, we could not show that inhibition of ATM 
in endothelial cells affected expression or insulin-stimulated activation of PKB/Akt while the 
PI3-K inhibitor wortmannin, inhibited the latter. In addition, inhibition of ATM negatively 
regulated the phospho/total ratio of AMPK. We therefore postulate that the NO production 
elicited by inhibition of ATM, may not be as result of eNOS activity.  
A second important observation was that inhibition of ATM significantly enhanced 
phosphorylation of the p85 regulatory subunit of PI3-K. This would imply that ATM 
normally has an inhibitory effect on p85 phosphorylation and therefore PI3-K activation. 
We base this assumption on previous publications showing that Ku-60019 does not inhibit 
PI3K. This again indicates that ATM has a hitherto unexplored regulatory role in 
endothelial function.  
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Opsomming: 
 
Ataxia telangiectasia (AT) is a goed-gekarakteriseerde neurodegeneratiewe siekte a.g.v. ‘n 
genetiese afwyking in the Atm geen wat lei tot ‘n afwesige of lae uitdrukking van die ATM 
proteïen. Aangesien AT pasiënte geneig is om insulienweerstandigheid en aterosklerose 
te ontwikkel, was die doel van hierdie studie om die belang van die ATM proteïen in die 
endoteel, en sy rol in die seintransduksiepaaie betrokke by stikstofoksied (NO) produksie, 
te ondersoek. Om dit te bereik, was die eerste mikpunt om ‘n eie endoteelsel isolasie-
tegniek (ge-oes van normale en insulienweerstandige diere) te vestig. Ongelukkig was 
hierdie selkulture nie suiwer genoeg nie.Ten spyte daarvan dat hulle positief getoets het 
met ‘n endoteelsel-spesifieke kleurstof kon geen uitdrukking van eNOS, die sentrale 
ensiem verantwoordelik vir NO produksie, waargeneem word nie.  
Die res van die studie het van kommersiële aorta endoteelselle (AES) gebruik gemaak, en 
daar is gevind dat die inhibisie van die ATM proteïen met die spesifieke inhibitor, Ku-
60019, tot ‘n beduidende toename in NO produksie gelei het. Die voordelige impak van 
verhoogde NO produksie sluit die handhawing van vaskulêre homeostase, bevordering 
van angiogenese, inisiëring van DNA herstel deur p53 aktivering en inhibisie van 
gladdespiersel proliferasie in. Reaktiewe suurstofspesies (ROS) en reaktiewe 
stikstofspesies (RNS) wat ook a.g.v.verhoogde NO gegenereer word, kan egter beide 
beskermende sowel as skadelike effekte uitoefen. Voorbeelde sluit seldood a.g.v. hoë 
ROS konsentrasies in. Ku-60019 het egter nie tot ‘n toename in seldood van die AES gelei 
nie.   
Hierdie studie het vir die eerste keer aangetoon dat daar ‘n verwantskap tussen die 
endoteel ATM proteïen kinase en die produksie van NO bestaan. Die seintransduksie 
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paaie betrokke by NO produksie en glukose verbruik vorm ‘n interafhanklike netwerk. Die 
aktiwiteit van twee proteïen kinases, PKB/Akt en AMPK, is sentrale rolspelers in beide 
paaie. Albei hierdie kinases is daarvoor bekend dat hulle die eNOS ensiem fosforileer om 
NO te produseer, maar terselfdertyd ook lei tot AS160 fosforilering, wat tot GLUT 4 
translokering en glukose opname lei. Dis is voorgestel dat aktivering van die ATM proteïen 
‘n voorvereiste vir PKB/Akt aktivering mag wees en verder kan dit ook tot aktivering van 
AMPK lei. Ons kon nie aantoon dat inhibisie van ATM in endoteelselle die uitdrukking of 
insulien-geïnduseerde aktivering van PKB/Akt onderdruk nie, terwyl die PI3-K inhibitor, 
wortmannin, wel laasgenoemde geïnhibeer het. Verder het die inhibisie van ATM die 
fosfo/totale AMPK verhouding negatief gereguleer. Ons postuleer dus dat die NO 
produksie waargeneem tydens ATM inhibisie, moontlik nie die gevolg van eNOS aktiwiteit 
was nie.  
‘n Tweede belangrike waarneming was dat die inhibisie van ATM die fosforilering van die 
p85 regulatoriese subeenheid van PI3-K beduidend laat toeneem het. Dit impliseer dat 
ATM normaalweg ‘n inhibitoriese effek op p85 fosforilering, en dus PI3-K aktivering, het. 
Hierdie aanname word gemaak n.a.v. vorige publikasies wat getoon het dat Ku-60019 nie 
PI3-K inhibeer nie. Dit dui weer eens daarop dat ATM ‘n tot nog toe onbekende 
regulatoriese rol in endoteelfunksie het. 
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Chapter 1: Introduction 
 
Ataxia telangiectasia (AT) is an autosomal recessive disease with an early onset in 
children. The disease is characterized by the presence of telangiectasias (red focal lesions 
due to the dilatation of small blood vessels) in the conjunctivae of the eye and body as well 
as an unsteady gait caused by muscle atrophy [Li, Y. and Yang, 2010]. Patients with this 
disease also show symptoms of neurodegeneration, an increased risk of cancer 
development, sensitivity to ionizing radiation, and, of importance to the current study, 
insulin resistance [Yang and Kastan, 2000]. 
Ataxia telangiectasia occurs when the ataxia telangiectasia mutated (ATM) protein is 
absent or inactive [Yang et al., 2011]. ATM is a 350-kDa protein and encoded by the Atm 
gene (figure 1.1). This protein is a member of the phosphatidylinositol-3 kinase related 
kinase (PIKK) family and phosphorylated at a conserved serine-threonine region followed 
by a glutamine (S/T/Q) [Bensimon et al., 2011]. Often the lack of ATM activity is caused by 
a mutation during protein translation or during the cell cycle.  
On average, AT patients have a lifespan of approximately 30 years and often die from 
cancer. In the general population insulin resistance, glucose intolerance and type 2 
diabetes mellitus usually develop at the age of 40-50 years. In contrast, many AT patients 
present with insulin resistance and glucose intolerance at a younger age (second to third 
decade of life), and are undiagnosed in most cases [Yang et al., 2011]. In the literature, it 
is reported that some AT patients present with symptoms and signs of the metabolic 
disease, including obesity, increased low-density lipoprotein (LDL) cholesterol levels, and 
low concentrations of high-density lipoprotein (HDL), [Schneider et al., 2006].  
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Figure 1.1: Diagram of the ATM protein [Stracker et al., 2013]. ATM has four 
autophosphorylation sites namely S367, S1893, S1981 and S2996. The ATM protein has 
two FKBP12-rapamycin-associated protein (FRAP), ataxia-telangiectasia mutated (ATM), 
Transformation/transcription domain-associated protein (TRRAP; FAT) domains, FAT 
1963-2566 and FAT C-terminal (FATC). 
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1.1. The metabolic syndrome, diabetes mellitus and atherosclerosis: risk factors for 
the development of cardiovascular disease (CVD) development 
 
1.1.1. The metabolic syndrome 
Many lifestyle factors, which include diet, smoking or excessive alcohol intake can 
contribute to the development of the metabolic syndrome [Mercer at al., 2010]. Individuals 
are diagnosed with the metabolic syndrome when they present with at least three of the 
following risk factors: hypertension, decreased HDL, increased LDL, central obesity and a 
high fasting blood glucose concentration [Mercer et al., 2010]. The metabolic syndrome is 
closely associated with other risk factors such as insulin resistance, glucose intolerance, 
diabetes and cardiovascular disease.  The metabolic syndrome is a complex disorder, and 
affects multiple organ systems in the body. In some cases, the disease can be reversed by 
lifestyle changes with or without therapeutic treatment, whereas in other cases, if 
untreated, it can be fatal [Zreikat et al., 2014; Chen, B. et al., 2012].  
 
Two different studies conducted in South Korea and Finland assessed the risk of 
developing both diabetes and cardiovascular disease in individuals presenting with the 
metabolic syndrome. In the study by Khang et al. (2010), the risk of developing 
cardiovascular disease and diabetes was measured in Asian individuals with the metabolic 
syndrome using a national longitudinal data set (Harmonization definition) [Khang et al., 
2010].; In their results section their study indicated that the metabolic syndrome was 
independently and significantly associated with the development of CVD and diabetes 
[Khang et al., 2010]. Conversely, in the study conducted in Finland by Pajunen et al. 
(2010) the development of heart disease and diabetes was evaluated in individuals who 
met the different definitions of metabolic syndrome as well as the relatively new 
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Harmonization definition. The study included both baseline and follow-up metabolic 
measurements (height, weight, waist circumference and blood pressure). Their results 
indicated that in people who have the metabolic syndrome, there is a greater risk of 
developing diabetes than cardiovascular disease at the follow-up consultation [Pajunen et 
al., 2010].  
 
1.1.2. Type 2 diabetes mellitus 
In a healthy individual, insulin is secreted by the pancreatic beta cells. Insulin mediates the 
uptake and metabolism of glucose in tissue types like skeletal muscle. Diabetes occurs 
when the body is unable to respond to the secretion of insulin (insulin resistance) resulting 
in hyperglycaemia. Under healthy conditions when insulin is released by the pancreatic 
beta cells, the phosphatidylinositol-3 kinases (PI3-K) pathway is activated in insulin-
sensitive peripheral tissue. Following this downstream proteins like PKB/Akt are 
phosphorylated, which activate a host of downstream signalling pathways involved in 
glucose uptake, nitric oxide (NO) production, angiogenesis as well as playing an important 
role in controlling the cell cycle and cell survival (figure 1.2).  
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Figure 1.2: A diagram listing the different signalling pathways in which PKB/Akt plays a 
role in; [http://what-when-how.com/cardiomyopathies-from-basic-research-to-clinical-
management/insulin-resistance-and-cardiomyopathy-metabolic-and-drug-induced-
cardiomyopathies-part-1/] 
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1.1.2.1. Activation of the PI3-K pathway in an insulin dependent manner 
Insulin binds to its receptor tyrosine kinase and stimulates the autophosphorylation of the 
tyrosine residues on the β-subunit, leading to insulin receptor substrate (e.g. IRS-1) 
phosphorylation [Hotamisligil et al., 1996 and Liu et al., 2009].  IRS-1 binds the PI3-K 
protein, which has been recruited, to the inner wall of the cell membrane. There are three 
classes of PI3-K, including Class IA, which has a regulatory subunit (P85) and catalytic 
subunit (P110), [Irarrazabal et al., 2006]. PI3-K is phosphorylated at the P85 regulatory 
subunit when treated with insulin. Once activated, PI3-K phosphorylates the membrane-
bound protein phosphatidylinositol 4,5-bisphosphate (PIP2) into  phosphatidylinositol 
3,4,5-trisphosphate (PIP3). PIP3 mediates the phosphorylation of PKB/Akt at Thr308, 
through activation of phosphatidylinositol dependent kinase 1 (PDK1). Following this 
PKB/Akt is immediately phosphorylated at Ser473 by phosphatidylinositol dependent 
kinase 2 (PDK2) to elicit its full function. PDK2 is an unidentified protein and researchers 
speculate that this protein can either be mammalian target of rapamycin (mTOR), DNA-PK 
or ATM as all of these proteins form part of the PIKK (figure 1.3), [Jensen et al., 2011 and 
Wymann and Morone, 2005]. 
1.1.2.2. Glucose uptake 
Once insulin mediated activation of PKB/Akt occurs, PKB/Akt phosphorylates the Akt 
substrate (AS160) protein at Ser588 (AS160 has six phosphorylation sites, Ser588 is the 
phosphorylation site which is most responsive to insulin). AS160 is a Rab GTPase 
activating protein (GAP). Rab GAP proteins are responsible for controlling the transfer of 
proteins through the membrane and for hydrolysing Guanosine-5'-triphosphate (GTP) 
binding proteins (considered the active state) to the Guanosine diphosphate (GDP) form 
(the inactive state). AS160 prevents glucose transporter-4 (GLUT4) vesicle translocation to 
the cell membrane and phosphorylation of AS160 alleviates this inhibitory effect [Jensen et 
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al., 2011; Treebak et al., 2006; He et al., 2007]. There are 13 various GLUT proteins; 
GLUT4 is the main glucose transporter that is activated by insulin. GLUT4 translocates to 
the cell membrane, fuses with the plasma membrane and mediates the uptake of glucose 
into the cells (Figure 1.3), [He et al., 2007; Eguez et al., 2005].  
Simultaneously, glycogen synthase kinase 3β (GSK3β) is another protein downstream 
PKB/Akt. GSK3β plays a role in many signalling proteins including protein synthesis, 
glycogen metabolism and regulating the cell cycle [Vara et al., 2004 and Yang and Li, 
2008]. In response to insulin GSK3β is inactivated by phosphorylation at Ser9 by PKB/Akt 
[Razani et al., 2010; Jensen et al., 2011]. Glycogen synthase (GS) is a protein responsible 
for the conversion of unused glucose into glycogen and its subsequent storage. The 
activity of glycogen synthase is inhibited by GSK3β. Thus when GSK3β is deactivated 
more glucose is converted to glycogen due to the increase in GS activity [Jensen et al., 
2011]. 
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Figure 1.3: Insulin mediated glucose uptake pathway [Jensen et al., 2011]. 
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1.1.2.3. Insulin insensitivity  
As mentioned, AT patients display insulin insensitivity and glucose intolerance, which 
poses interesting questions about the importance of the ATM protein in insulin sensitivity 
and glucose homeostasis. In patients with the metabolic syndrome and in AT patients 
insulin is present in skeletal muscle and brown adipose [Mookerjee et al., 2010] as well as 
the vasculature at basal concentrations but the cells are not responding, and therefore 
cellular processes mediated by insulin are left incomplete. 
During insulin resistance, it is over active phosphatase and tensin homologue deleted on 
chromosome 10 (PTEN) which contributes to the development of this disease. PTEN has 
dual function as both a lipid and a protein. When active PTEN dephosphorylates PIP3 
[Vara et al., 2004 and Mukherjee et al., 2013] at its D3 position, thereby negatively 
regulating the insulin mediated PI3K and PKB/Akt pathway [Weichhart and Säemann, 
2008]. PTEN often defined as a tumour suppressor protein plays a role in many signalling 
pathways including cell motility, cell senescence and chromosomal stability. When 
inactivated, PTEN has been discovered to promote cancer progression [Wymann and 
Marone et al., 2005], and enhances GLUT4 translocation to the cell membrane to increase 
glucose uptake and increases insulin sensitivity [Hirsch et al., 2007]. 
ATM, a known member of the PIKK family, plays a role in the activation of PKB/Akt at 
Ser473 in response to insulin treatment. When ATM is inhibited or absent in cells there is a 
decrease in PKB/Akt activation and glucose uptake and an increase in insulin resistance 
[Yang et al., 2011]. Various studies have investigated the effects of silencing AS160 on 
insulin mediated glucose uptake via GLUT4 as well as the role of other glucose 
transporters in ATM deficient cell types. According to Halaby et al. glucose uptake by 
GLUT4 mediated by insulin was inhibited in L6 muscle cell lines when treated with the 
ATM inhibitor Ku-55933 [Halaby et al., 2008]. Andrisse et al. (2014) confirmed that GLUT1 
is expressed and fully functional in the absence of a functional ATM protein and observed 
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that when this occurs there is an increase in insulin resistance in skeletal muscle cells 
[Andrisse et al., 2014].  
 
1.1.3. Atherosclerosis development 
Insulin resistance and type 2 diabetes are independent risk factors for atherosclerosis, 
which is labelled an inflammatory disease [Ray et al., 2009]. Endothelial dysfunction, 
characterised by reduced NO bioavailability and hence reduced ability of blood vessels to 
dilate, is an early biomarker of atherosclerosis [Li and Keaney, 2010]. There are various 
factors that contribute to the development of endothelial dysfunction and atherosclerosis, 
which include oxidative stress, oxidation of low-density lipoprotein (LDL) and inflammation 
[]Semlitsch et al., 2011. 
An atherosclerotic plaque develops when a lesion occurs in the endothelium exposing the 
smooth muscle cells in the vasculature. When this occurs, chemo-attractants are released 
and monocytes are drawn to and adhere to the injured site. Proteins involved in the 
inflammatory process of atherosclerosis are monocyte chemo-attractant protein-1 (MCP-
1), vascular cell adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 
(ICAM-1), [Nickenig and Harrison, 2002]. When drawn to the injured site monocytes 
differentiate into macrophages and these monocyte-derived macrophages turn into foam 
cells. Foam cells develop when the macrophage-derived monocytes take up oxidized low-
density lipoprotein (ox-LDL), forming fatty streaks [Nickenig and Harrison, 2002; Kuo et al., 
2009].  
Oxidized LDL is produced by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) or 
lipoprotein lipase (LPL) under various conditions. During foam cell formation the monocyte 
derived macrophages express lipoprotein lipase (LPL). LPL, which is up-regulated in 
diabetes, is responsible for membrane synthesis and hydrolyses chylomicrons and very 
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low-density lipoprotein (VLDL), [Basu et al., 1976]. The free cholesterol generated by the 
hydrolysis process is taken-up by macrophages. The ox-LDL is insoluble and it takes 
longer for the smooth muscle cells to remove the lipids from the intimal space, which 
results in the over accumulation of these cells and foam cell formation (Figure 1.4), [Mead 
and Ramji, 2002].  
 
Figure 1.4: Atherosclerotic plaque development and progression [Dandona and Aljada, 
2002]. 
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Atherosclerosis development and progression is accompanied by oxidative stress, 
whereby the amount of reactive species exceeds the availability of antioxidants (for 
example manganese super oxide dismutase (Mn-SOD) and malondialdehyde (MDA)) in 
the cell [Yin, et al., 2007]. The most common reactive species is superoxide anion (O2-). In 
addition to traditional ROS sources such as NADPH-oxidase and mitochondria, 
dysfunctional vascular endothelial cells generate superoxide anions via endothelial nitric 
oxide synthase (eNOS) when it uncouples due to, among others, the loss of its cofactor 
tetrahydrobiopterin (BH4). When BH4 is absent or inactive, electrons are transferred to an 
oxygen molecule instead of L-arginine [Nickenig and Harrison, 2002]. Other mechanisms 
of ROS formation include damage to the mitochondrial respiratory system [Semenkovich, 
2006] and the NADPH oxidase.   
Apoptosis of smooth muscle cells (SMC) in the atherosclerotic plaque leads to plaque 
instability and rupture. Often the onset of SMC apoptosis is caused by the activation of 
angiotensin receptor AT1 [Nickenig and Harrison, 2002]. Both insulin resistance and 
atherosclerosis can cause DNA damage, which leads to the activation of the protein ATM 
[Semenkovich, 2006]. ATM is inactive in AT patients and it was observed that people with 
a single copy of the defective ATM gene (carriers) are susceptible to developing 
cardiovascular disease. This was demonstrated in a study completed by Yang et al.; 
whereby mice heterozygous for ATM+/- and who were also Apolipoprotein E  null (ApoE-/-) 
were found to have a higher incidence of developing atherosclerosis, insulin resistance 
and glucose intolerance. These pathologies were induced after the mice were fed a high 
fat diet compared to ATM+/+ApoE-/- mice fed the same diet [Yang et al., 2011; Hammond 
and Giaccia, 2004 and Schneider et al., 2006]. 
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1.2. The importance of the endothelium in vascular health  
1.2.1. Endothelial dysfunction and cardiovascular disease 
Vascular endothelial cells have been the topic of research for many years. Without the 
endothelial cells and their role in vascular homeostasis, people would be at a higher risk of 
developing cardiovascular disease (CVD) and dying from a CVD related pathology. 
According to Kuliszewski et al. (2013), mature endothelial cells that have differentiated 
from endothelial progenitor cells (EPC) play and important role in repair and tissue 
regeneration when damage occurs in the vasculature [Kuliszewski et al., 2013]. Under 
hypoxic conditions and during peroxynitrite (ONOO-) formation in the endothelial cells, 
AMP-activated protein kinase (AMPK) is activated. AMPK is an energy sensor that is 
activated by increased concentrations in AMP and maintains intracellular homeostasis 
under stressful conditions (e.g.  DNA strand breaks and oxidative stress), [Wang, S. et al., 
2012]. The endothelial cells constitutively express the enzyme eNOS which produces NO. 
NO is responsible for vasodilation and inhibits the proliferation of smooth muscle cells 
(SMCs), [Venugopal et al., 2002]. A decrease in eNOS activity is associated with 
cardiovascular pathologies such as hypoxia, oxidative stress and is often a precursor for 
atherogenesis [Li, H. et al., 2014 and Razani et al., 2008]. It has been suggested that the 
endothelial cell may play an important role in the insulin-induced uptake of glucose by the 
skeletal muscle [Kubota et al., 2011]. 
 
1.2.2. The function and importance of aortic endothelial cells (AECs) in 
vascular health 
The vascular endothelium (ECs) plays a pivotal role in the maintenance of vascular 
homeostasis [Jaffe et al, 1973]. They fulfil this role by, among others, regulating the 
transfer of molecules across the semi-permeable endothelial layer, and releasing NO and 
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other vasoactive factors [Sumpio et al, 2002]. NO is synthesised by a family of enzymes, 
called the NO synthases (NOS). There are three different NOS isoforms, namely neuronal 
NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2) and endothelial NOS (eNOS or 
NOS3) [Carnicer et al., 2013; Förstermann and Sessa, 2012]. The NOS isoforms are 
located in various parts of the body and in different subcellular regions, and they release 
NO in concentrations that range in the nano- and micro- molar range [Strijdom et al., 2009 
and Mian et al., 2013].  
 
In AECs, the protein PKB/Akt phosphorylates eNOS in response to insulin [Taguchi et al. 
2012]. eNOS, which is constitutively expressed in both vascular endothelial cells and 
cardiomyocytes, is responsible for the release of NO from the amino acid substrate L-
arginine in the presence of oxygen. In order to generate NO, eNOS requires 
phosphorylation (and therefore activation) at Ser1177, as well as the presence of 
substrates (L-arginine, tetrahydrobiopterin), co-substrates (oxygen and NADPH: 
nicotinamide-adenine-dinucleotide phosphate), cofactors (FAD: flavin adenine dinucleotide 
and FMN: flavin mononucleotide) and a calmodulin (CaM) binding site [Carnicer et al., 
2013; Förstermann and Sessa, 2012]. The carboxy-terminal of eNOS is responsible for the 
transfer of electrons from NADPH to the haeme group via FAD and FMN. At the amino-
terminal oxidase; tetrahydrobiopterin (BH4), oxygen and L-arginine bind. The electrons 
transferred from NADPH are used to reduce oxygen and oxidize (catabolize) L-arginine to 
form L-citrulline and release NO (figure 1.5). 
Collectively, the endothelial cells are important for angiogenesis and are responsible for 
cell survival, proliferation and migration [Levine et al., 2003 and Joshi et al., 2013]. 
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Figure 1.5: Diagram showing the structure and domains of an eNOS enzyme in a dimer 
conformation. The diagram depicts the pathway the electrons follow during NO formation. 
[Stuehr et al., 2005] 
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1.3. Conclusion 
For many years endothelial cells have been the topic of research ranging from the first 
endothelial cell isolation by Jaffe and his colleagues (1973) to the unknown endothelium-
derived relaxing factor (EDRF) later known as NO. Endothelial cell dysfunction disrupts the 
maintenance of vascular homeostasis. This disruption leads to the development of various 
forms of cardiovascular disease, increases ROS production, negatively impacts glucose 
uptake and activates inflammatory responses. Due to these reasons and the increasing 
prevalence of CVD, research on endothelial cells remains relevant in this present age.  
There is a limited amount of data available on the presence and function of the ATM 
protein in AEC. Although few studies have explored the role of the ATM protein in ApoE-/- 
mice and the development of atherosclerosis [Mercer et al. 2010], it has not been 
determined whether or not AT patients have a higher incidence of developing 
cardiovascular disease due to the mutation in the Atm gene. Some studies suggest that 
the lack of ATM protein present in AT patients could promote the onset of atherosclerosis 
and mitochondrial dysfunction (increasing ROS production), [D’Souza et al., 2013]. A study 
completed by Mercer et al. investigated the prevalence of atherosclerosis development in 
heterozygous carriers of the mutated Atm gene. In this study, the possible mechanisms by 
which ATM heterozygosity could lead to atherosclerosis development were outlined (figure 
1.6). 
The role of the ATM protein and its function has been researched extensively especially in 
relation to PKB/Akt. PKB/Akt is a diverse protein that plays a role in different cellular 
processes. In this research topic, the role of PKB/Akt mediated by ATM in response to 
insulin treatment is of great interest concerning endothelial dysfunction and vascular 
pathology.  
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Figure 1.6: A proposed mechanism on how an inactive ATM protein could influence the 
onset of atherosclerosis [Mercer et al., 2010]. 
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Chapter 2: Literature review 
2.1. The ATM protein 
The gene encoding the ataxia telangiectasia mutated (ATM) protein was first discovered in 
1995 [Savitsky et al., 1995]. In addition to muscle atrophy and telangiectasia’s, patients 
with ataxia telangiectasia (AT) are known to age prematurely, have stunted growth, display 
chromosomal instability, be predisposed to cancer, have increased requirements for serum 
growth factors and show sensitivity towards ionizing radiation. On average an AT patient 
has a lifespan of 20-30 years [Savitsky et al., 1995]. 
The ATM protein is a dimer when it is inactive and monomerizes when activated by DNA 
damage (figure 2.1). ATM is mostly localized in the nucleus where it stimulates and 
activates many other proteins involved in various cellular processes (figure 2.2). Due to the 
nature of these proteins and their localization in other parts of the cell, many research 
groups have not only investigated the nuclear function of the ATM protein but also the 
localization and function of the protein in the mitochondria and the cytoplasm.  
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Figure 2.1:Dimer dissociation and activation of the ATM protein [Stracker et al., 2013]. The 
ATM dimer protein is activated by DNA damage and oxidative stress. DNA damage 
causes autophosphorylation at Ser1981 in humans. Oxidative stress causes dimerization 
and sulphur bonds between two ATM monomers. 
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Figure 2.2: Diagram depicting the many proteins activated by ATM in response to DNA 
double strand breaks. Each protein or multiple proteins play a role in signalling pathways 
involving DNA repair, cell cycle arrest, apoptosis and chromatin remodelling within the 
nucleus [Khalil et al., 2012]. 
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2.2. Activating the ATM protein – the nuclear function of ATM 
DNA damage is an event that occurs due to abnormalities in the synthesis of DNA. Often 
these abnormalities occur under physiological conditions or can be induced by various 
treatments and environmental stress [Shiloh, 2003]. Physiological conditions include base 
mismatches, which occur during DNA replication, inactivation of topoisomerases I and II, 
formation of cell lesions, oxidative stress caused by reactive oxygen species (ROS), and 
depurination. Drug induced DNA damage is believed to be a result of the Fenton reaction 
facilitated by excessively high concentrations of metals. Often these compounds either 
lead to single strand breaks (SSBs) or double strand breaks (DSBs). Of these two, DSBs 
occur seldom, are hard to repair and can be fatal [Mahmoudi et al., 2006].  
It has been described that DSBs arise when two SSBs occur near to each other or when 
there is one SSB and a lesion in close proximity. These lesions include impaired base 
pairing, inhibition of DNA replication and transcription as well as base loss [Jackson and 
Bartek, 2009]. Other factors involved with the onset of DNA damage include smoking, 
diabetes mellitus and ionizing radiation. Smoking and DNA damage occur due to the ability 
of tobacco-related toxins to inhibit DNA repair, promote oxidative stress and stimulate the 
production of advanced glycation end-products (AGEs) which are believed to cause DNA 
mutations. Selenium-treatment has also been found to promote oxidative stress, which 
induces DNA damage [Rocourt et al., 2013]. Exposure of cells to ionizing radiation can 
also induce DSBs. It is believed that ionizing radiation not only causes DNA strand breaks, 
but can also alter the formation of chromatin structure. Chromatin structure is known to be 
altered by the induction of various agents which include hypotonic conditions, chloroquine 
and histone deacetylase inhibitors. Although none of these agents cause DNA strand 
breaks, they are thought to stimulate the phosphorylation of proteins in the DNA damage 
response. Furthermore, it has been observed that DSBs can occur during both meiotic and 
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V(D)J recombination [Bakkenist and Kastan, 2003; Khanna et al., 2001 and Bensimon et 
al., 2011]. 
 
2.2.1. The DNA damage response 
The cellular DNA damage response (DDR) aims to repair DNA lesions, both SSBs and 
DSBs and is known for controlling the cell cycle checkpoints [Bensimon et al., 2011; 
Jackson and Bartek, 2009]. The DDR has been shown to utilize different and distinct repair 
mechanisms. 
The first mechanism is the so-called mismatch repair, which is commonly used to repair 
mismatches or insertion/deletion loops by enzymes like nuclease, polymerase and ligase. 
The second is the base excision repair mechanism, which not only consists of the above 
mentioned enzymes, but additionally also DNA glycosylase responsible for removing 
unwanted base pairs. Base excision repair can also be used in the repair of SSBs. The 
third repair mechanism is nucleotide excision repair (NER) which consists of two sub-
mechanisms namely; transcription-coupled NER and global genome NER. Both of these 
target lesions [ackson and Bartek, 2009]. 
In the case of DSBs the cells have two mechanisms to combat these breaks, the first is 
non-homologous end joining (NHEJ) and the second is homologous recombination (HR). 
Some of the other mechanisms employed to combat DNA damage are antioxidants such 
as ascorbic acid, glutathione and others, which fight DNA damage caused by oxidative 
stress [Mahmoudi et al., 2006; Jackson and Bartek, 2009]. When the DNA damage 
becomes irreparable, it could lead to cell death through apoptosis (Figure 2.3), [Khalil et 
al., 2012].  
There are various proteins involved with the DDR, which either control, or are involved in 
the cell life cycle. According to Mahmoudi et al. (2006) there are three steps in the DDR to 
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repair DNA damage, these steps consists of sensors, transducers and effectors. Sensors 
are responsible for detecting lesions and changes in chromatin structure after DNA 
damage has occurred.  Sensors are a group of proteins called the meiotic recombination 
11 (Mre11), DNA repair protein Rad50 (RAD50) and Nijmegen breakage syndrome 
(NBS1), also known as the MRN complex [C. Chen et al., 2013]. Transducers are proteins 
that initiate a host of signalling events that reverse the DNA damage. Mahmoudi et al. 
(2006) identified two transducer proteins namely; ATM and ATM Rad3-related protein 
(ATR) [Mahmoudi et al., 2006]. Lastly, are the effectors that are considered to complete 
the DDR, as they are responsible for carrying out the final response relayed by the 
sensors to the transducers. Both Chk1 and Chk2 proteins have been labelled as effectors 
as they are both downstream from the ATM and ATR proteins.  
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Figure 2.3: The role of ATM in response to DNA damage [Watters, 2003]. ATM is 
considered a transducer protein as it activates many proteins involved in controlling the 
cell cycle, DNA repair and apoptosis. 
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2.2.2. Proteins involved in the DDR 
There is a wide spectrum of proteins involved in the DDR. As mentioned earlier some of 
these include the MRN complex, the ATM protein, ATR protein and Chk1 and Chk2. But 
other proteins involved with the DDR include DNA-dependent protein kinase (DNA-PK), 
Ku, PKB/Akt, the mitogen activated protein kinase (MAPK) family and many more, each 
with their own functions. It has been proposed that the MRN complex stimulates 
homologous recombination, which responds to SSBs [Jackson and Bartek, 2009]. Each 
protein in the MRN complex has a specific role to play. MRE11 has both endonuclease (for 
both single and double stranded DNA) and exonuclease activity, but most importantly, it 
possesses the binding domain for NBS1. The RAD50 protein is considered to function as a 
dimerization domain as it comprises of an ATP cassette accompanied by two coiled-coil 
domains. The NBS1 is critical for the transportation of the MRN to the nucleus and the 
binding of phospho-H2AX at sites of DSBs [Mahmoudi et al., 2006].   
The H2AX histone protein is an indicator of DNA damage as it is rapidly phosphorylated 
after cell exposure to ionizing radiation [Bakkenist and Kastan, 2003]. Both ATM and DNA-
PKcs at Ser-139 can phosphorylate the H2AX protein [Rocourt et al., 2013]. Once DNA 
damage occurs, aggregates of phospho-H2AX assemble at the locations of DNA damage, 
at which point the damaged DNA recruits the MRN complex and activates the DDR 
[Shiloh, 2003].   
The ATM protein is recruited to the site of DSB by the MRN complex and is auto-
phosphorylated at Ser1981 [Rocourt et al., 2013]. The ATM protein in turn phosphorylates 
downstream proteins, involved in the cell cycle (Figure 2.4). The first of these proteins are 
Chk1 (activated by ATR) and Chk2. Chk1 and Chk2 with ATM have been observed to 
reduce or inhibit the activity of cyclin dependent kinases (CDKs). According to Y. Shiloh 
(2003) both Chk1 and Chk2 phosphorylate CDC25A, a phosphatase protein. CDC25A is 
responsible for the dephosphorylation of the cyclin dependent kinases and maintains the 
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activity of CDK1 and CDK2. The dephosphorylation of  CDK2 activity brings about a halt in 
the cell cycle at the G1-S phase which will provide enough time for damaged DNA to be 
repaired before DNA replication occurs and mitosis completes which is promoted by CDK1 
[Shiloh, 2003; Jackson and Bartek, 2009; Mercer et al., 2010 and Bensimon et al., 2011]. 
The tumour suppressor p53, is known to play an integral role in detaining the cell cycle at 
the G1/S phase [Bakkenist and Kastan, 2003]. The ATM protein is known to activate the 
tumour suppressor gene, p53 by phosphorylating it at Ser15. Chk2 is also thought to 
activate p53 at Ser20 by phosphorylation, which impedes binding between p53 and MDM2 
(figure 2.4), [Shiloh, 2003]. P53 is known to promote apoptosis in cells where the DDR 
could not be effective, or where senescence induced either by DNA-PKcs or selenium, is 
not successful [Rocourt et al., 2013]. 
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Figure 2.4: DNA damage repair mechanisms [Khalil et al., 2012]. The DNA damage 
response pathway activates p53 and the CHk1/2 proteins to arrest the cell cycle at the 
G1/S phase and G2/M phase respectively. Inhibition of cyclin dependent kinases (CDKs) 
and phosphorylation of the protein phosphatases are required for the repair mechanisms 
to occur. 
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In DSBs the non-homologous end joining (NHEJ) is identified by the Ku heterodimer (Ku70 
and Ku80) which forms the catalytic subunit of the DNA-PK referred to as DNA-PKcs. The 
Ku heterodimer is responsible for binding to the DNA-PK and activating it to attract 
polymerases and DNA ligase IV to the damaged DNA site in order to repair it. The DNA-
PKcs protein can be phosphorylated in two ways. The first is auto-phosphorylation at Ser-
2056 which aims to repair NHEJ. The second is phosphorylation by ATM at Thr-2647, 
often due to ionizing radiation [Shiloh, 2003; Bensimon et al., 2011 and Rocourt et al., 
2013] 
The ATM protein is a member of the PI3-K-related family of kinases (PIKK). There are 
several other proteins that are a part of this family namely, ATR, mTOR/FRAP, TRRAP 
and DNA-PK [Bensimon et al., 2011].   
Y. Shiloh suggested that proteins commonly involved in stress response pathways might 
play a role in the DDR. The activation of these proteins is normally independent of ATM, 
but when they are stimulated by the DDR their activity is ATM dependent. Examples of 
these proteins include MAPK and NFκB [Shiloh, 2003]. Once activated MAPK in turn 
activates ERK1/2. Subunits of the MAPK, p38 is known to be activated more dynamically 
by UV radiation than by ionizing radiation [Shiloh, 2003].  
In addition to the DDR response, ATM activates other proteins as well; most of them have 
more than one function within the cell. These proteins are PKB/Akt and BRCA1. The ATM 
protein activates PKB/Akt during DNA damage caused by ionizing radiation. PKB/Akt is a 
member of the PI3-K signal transduction pathway and has many functions in the cell 
related to glucose uptake, cell progression and signalling pathways activated by insulin or 
IGF-1. The BRCA1 protein plays a role in the S-phase and the G2/M checkpoint of the cell 
cycle and initiates the expression of various DDR genes [Shiloh, 2003]. AMPK has been 
found to be activated by ATM in response to DNA damage. Activation of AMPK occurs 
independently from liver kinase B1 (LKB1) [Amatya et al., 2012]. Although LKB1 does not 
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activate AMPK it does result in the activation of mTOR complex 1 (mTORC1) and its 
signalling pathway together with TSC2 and hypoxia induced factor 1 alpha (HIF1α). The 
ATM protein is responsible for the activation of mTORC1 via this pathway (figure 2.5), 
[Guo et al., 2010].  
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Figure 2.5: Cytoplasmic activation of ATM by ROS and its role in cell growth and 
autophagy [Ditch and Paull, 2012]. 
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2.2.3. DNA damage and heart disease 
Jackson and Bartek (2009) described that the activation of p53 is damaging in pathologies 
such as strokes and heart attacks. They also reported that the activation of p53 due to 
DNA damage could contribute to the development of atherosclerosis. The latter was 
attributed to senescence of vascular cells or cell death, which leads to the atherosclerosis 
lesion formation when the DDR is ineffective [Jackson and Bartek, 2009].  Similarly, 
Mercer et al. (2010) stated that there is a direct correlation between DNA damage and 
atherosclerosis (endothelial dysfunction; figure 2.6), and that either atherosclerosis or DNA 
damage will increase as the other progresses [Mercer et al., 2010]. Mahmoudi et al. (2006) 
argued that DNA damage occurs in both circulating cells and cells within the 
atherosclerotic plaque. They highlighted that early onset of atherosclerosis is an indication 
of failed DNA repair and pathologies like Werner syndrome, which is characterized by 
patients often showing signs of atherosclerosis, premature aging, cancer, osteoporosis, 
cataracts and diabetes [Mahmoudi et al., 2006].  
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Figure 2.6: The role of ATM in the vasculature. First ATM is activated by the MRN complex 
in response to DNA damage caused by ionizing radiation. The ATM protein s dimer 
formation monomerizes into the active state. Secondly, ATM is activated by ROS and does 
dissociate from each other. Both ROS and DNA damage inhibit the proliferation and 
survival of endothelial cells [Kerr and Byzova, 2012]. 
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2.2.4. DNA damage and cell pathology 
Various studies have investigated several aspects of DNA damage. Throughout all of this, 
there appears to be a general theme, which includes the role of oxidative stress and the 
ATM protein. It is generally accepted that oxidative stress can cause DNA damage (cell 
nucleus or mitochondrial DNA; figure 2.7). This stems from the fact that the mitochondria 
are mainly responsible for cellular respiration, which releases reactive oxygen species 
(ROS) as a by-product. ROS is produced by different processes and contributes to the 
formation and progression of atherosclerotic plaques. DNA damage, which mostly occurs 
due to abnormally high levels of ROS, has been linked to atherosclerosis development 
[Mahmoudi et al., 2006]. This ‘theory’ is supported by the fact that in patients where the 
DDR is ineffective, few of the repair proteins will be activated, replication and mitosis will 
continue resulting in increased coding of mutated genes. This inevitably results in severe 
pathologies like that of Werner syndrome and Ataxia telangiectasia, as well as a much 
higher risk of developing cardiac disease, diabetes mellitus and the metabolic syndrome. 
In addition, there is a greater risk of developing cancer. 
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Figure 2.7: The role of ATM in response to DNA damage and ROS. (A) diagram depicting 
the dual role of ATM in response to both DNA damage and oxidative stress. (B) Indicates 
the adverse effects of ROS in the system when the protective role of ATM is inhibited [Guo 
et al., 2010]. 
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2.3. Oxidative stress 
The ATM protein is known not only as a sensor of DNA damage but also as a sensor for 
oxidative stress and oxidative damage [Chen, B et al., 2012 and Andrisse et al., 2014]. 
There are different types of oxidative stress, which activates the ATM protein at ser-1981. 
The mechanism by which ROS is generated is divided into endogenous and exogenous 
production. ROS is produced endogenously by various cellular mechanisms, which include 
mitochondrial respiration, xanthine oxidase and the NADPH oxidase [Coyle et al., 2006]. 
ROS produced by these mechanisms include superoxide anion (O2-), hydrogen peroxide 
(H2O2), reactive nitrogen species (RNS) and hydroxyl radicals (OH). ROS is known to play 
an important role in maintaining cell signalling and gene expression. ROS is generated 
exogenously by the addition of chemicals (chemotherapeutic drugs, hydrogen peroxide 
(H2O2)) or exposure to ionizing radiation or ultraviolet (UV) light. ROS production and 
release occur during cellular stress, hypoxic conditions or as a result from pathologies 
such as insulin resistance and diabetes [Chen, B. et al., 2012].  
High cellular ROS concentrations are scavenged by antioxidants such as manganese 
superoxide anion dismutase (MnSOD), glutathione reductase, metal chelation thioredoxin 
and many more. When the concentration of ROS exceeds that of the antioxidants, the 
cellular redox homeostasis is lost, and oxidative stress ensues [Semlitsch et al.., 2011].  
ATM is an oxidative stress sensor and a deficiency in the activity of ATM is associated with 
high cellular concentrations of ROS, often observed in ataxia telangiectasia patients. The 
role of ATM as an oxidative stress sensor hints at the possible localization of the ATM 
protein in the mitochondria [D’Souza, et al., 2013].  
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2.3.1. Mitochondrial uncoupling  
Type 2 diabetes mellitus and atherosclerosis have several commonalities, one of them 
being oxidative stress, whereby the presence of ROS in a cell exceeds the protective 
effects of antioxidants, resulting in impaired glucose uptake [Mookerjee et al., 2010] and 
atherosclerosis development. Vascular endothelial cells possess mitochondria in the 
cytosol. The mitochondria is responsible for the energy status of the cell by maintaining the 
levels of ATP and it is also responsible for regulating processes like apoptosis, calcium 
signalling and the production of ROS [Mookerjee et al., 2010]. 
The mitochondria possess their own DNA (mtDNA) which encodes for the proteins 
involved in the electron transport chain (ETC) namely, complex I, III, IV and V (the ATP 
synthase). Within the ETC, electrons are donated to NAD+ and ubiquinone to generate 
NADH and ubiquinol. Both these molecules enter the ETC donating their electrons, which 
flows down a negative energy potential gradient in the mitochondrial inner membrane. The 
electrons enter the intermembrane space via complex I and are passed on to complex III 
and IV. Thereafter the protons are returned to the mitochondrial matrix by the proton 
motive force through complex V when ATP is generated [Mookerjee et al., 2010].    
Once ATP is generated, the electrons are donated to oxygen (O2) to generate H2O. In 
some cases, the electrons are believed to “escape” the ETC at complex I and III 
[Mookerjee et al., 2010 and Yu, E. et al., 2013]. These electrons bind to O2 and generate 
ROS in the form of superoxide anions (O2-). The O2- can form OH- radicals, which leads to 
extensive oxidative damage in cells.  
Damage to mtDNA causes mitochondrial dysfunction and stimulates inflammation in the 
cell as well as cell death and senescence. According to Yu, E. et al. (2013) the aortas of 
patients with atherosclerosis have a higher incidence of mtDNA oxidative lesions 
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compared with control groups, thereby lowering the effects of antioxidants and promoting 
the onset of atherosclerosis [Yu, E. et al., 2013].  
 
2.3.2. The NADPH oxidase 
The NADPH oxidase (Nox) consists of seven catalytic subunits namely, Nox1, Nox2, 
Nox3, Nox4, Nox5, Duox1 and Duox2 [Schramm et al., 2012]. The Nox enzymes are 
transmembrane proteins that transfer electrons from NADPH to O2 and produce O2-. 
Factors that activate the NADPH oxidase include growth factors and mechanical forces. 
One example includes the activation of the angiotensin II receptor, AT1. Once angiotensin 
II binds to AT1 it causes phospholipase C (PLC) activation, which results in the release of 
both diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 with DAG are considered to 
activate protein kinase C (PKC) by facilitating the release of calcium intracellularly. PKC is 
then believed to activate the NADPH oxidase through its activation subunit p47phox 
[Nickenig and Harris, 2002; Huang et al., 2011; Schramm et al., 2012].     
Only Nox1, 2, 4 and Nox5 are thought to be present in vascular tissue. Nox1 is present in 
vascular smooth muscle cells (VSMC), Nox2 and Nox5 in ECs, Nox2 in adventitial fat and 
VSMC whereas Nox4 is localized in all cell types. It has been described that Nox1, 2, 3 
and Nox4 possess a structural/functional subunit called p22phox and that Nox5 is calcium 
dependent [Huang et al., 2011]. Furthermore, Nox4 is the most abundantly expressed in 
ECs compared to the other Nox subunits. Nox4 activity is only dependent on p22phox and 
not p47phox, it was suggested that Nox4 is the least related member of the Nox family 
[Bretón-Romeros and Lamas, 2014]. 
In endothelial cells the NADPH oxidase produces O2- . Superoxide anions react with NO to 
produce peroxynitrite (ONOO-; figure 2.8). ONOO- is considered one of the most effective 
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markers of endothelial dysfunction.  Concurrently, O2- reacts with enzymes that stabilize 
the ROS by converting it into H2O2. H2O2 may further be broken down into a volatile form, 
which affects both HDL and LDL and promotes atherosclerosis plaque formation. It has 
been described that both iNOS, the inducible NOS isoform responsible for the generation 
of high amounts of NO, and Nox4 play a role in atherosclerosis; Nox4 in atherosclerosis 
development and Nox2 in atherosclerosis progression [Wang, H. et al., 2014]. 
Atherosclerosis progression occurs by the formation of foam cells due to the excess 
uptake of ox-LDL by monocyte-derived macrophages. 
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Figure 2. 8: Oxidative stress produced by the NADPH oxidase and the antioxidants which 
target ROS production [Khalil et al., 2012]. 
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2.3.2.1. Ox-LDL induced ROS production and ATM 
Many studies have explored the relationship between the ATM protein, ROS and RNS. 
Semlitsch et al. (2011) studied the putative protective role of ATM against ROS in the 
presence of oxidized low-density lipoprotein (oxLDL) and the looming onset of 
atherosclerosis. Their results showed that ox-LDL activated ATM in a time dependent 
manner and this activation was abrogated in cells treated with an ATM inhibitor. 
Furthermore, although ox-LDL inhibited the growth of ATM+/+ AND ATM -/- cell types, it 
had no effect on the survival of these cells. Ox-LDL was observed to increase ROS 
production in ATM-/- cell lines and cells inhibited with a specific ATM inhibitor. When 
functional ATM was activated by ox-LDL, ATM was found to elicit a protective effect 
against ROS production associated with the high levels of ox-LDL in vitro [Semlitsch et al., 
2011]. 
 
2.3.3. Atherosclerosis development in relation to ATM-/- and ATM +/- 
genotypes 
2.3.3.1. ROS, ATM and the induction/expression of HIF1α 
In ATM deficient patients, hypoxia-inducible factor 1α (HIF1α) is up-regulated. HIF1α is 
responsible for cellular adaptation to hypoxic conditions and promotes angiogenesis by 
regulating the expression of vascular endothelial cell growth factor (VEGF) and mediating 
the cell metabolism through glucose transporter 1 (GLUT1) [Ousset et al., 2010]. 
Ousset et al. (2010) hypothesized that HIF-1 biosynthesis was a result of the high levels of 
oxidative stress in ATM deficient cells [Ousset et al., 2010]. Their data suggested a direct 
link between the up-regulation of HIF1α and oxidative stress in AT patients and that ROS 
produced by the mitochondria partially stabilizes HIF1-α. HIF-1α stabilization leads to 
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increased tumour angiogenesis typical of cancer development in AT patients [Ousset et 
al., 2010]. 
2.3.3.2. The ATM protein and NFκB in response to oxidative stress 
NFκB is a transcription factor and regulates the oxidative stress response. NFκB activation 
is mediated by the presence of inflammation or by the ATM protein via IκB in response to 
DNA damage. In ATM deficient cells, the activation of NFκB was shown to be reduced 
[Watters, 2003]. 
2.3.3.3. The effects of antioxidant treatment for mitochondrial dysfunction in an 
ATM-/- mouse model 
Antioxidant therapy is a well-known and useful way of reducing intracellular ROS.  In a 
study completed by D’Souza et al. (2013), the antioxidant effects of catalase targeted to 
mitochondria (mCAT) on the clinical symptoms of AT in an ATM-/- mouse model, with 
regards to thymic function, a deficiency in the bone marrow hematopoiesis and 
dysfunctional memory CD8+ T-cells were investigated. Their data demonstrated that 
mitochondrial ROS production is responsible for the oxidative stress observed in AT. They 
observed an increase in thymocytes due to mCAT activity, but in the presence of cancer in 
the ATM-/- mice model, mCAT had no effect on the function of the thymus. It was also 
observed that the CD8+ T-cell function was partially restored. Lastly, although not 
significantly and irrespective of mCAT treatment, the bone marrow hematopoiesis declined 
in an age-dependent manner [D’Souza et al., 2013]. The data presented by this study 
indicated that although antioxidant therapy was successful in alleviating or postponing the 
symptoms of AT, it did not prevent morbidity or mortality arising from AT associated 
pathologies. 
Stellenbosch University  https://scholar.sun.ac.za
42 
 
2.3.4. Regulation of ROS by ATM and p53 
Ataxia telangiectasia and ATM deficiency lead to oxidative stress. P53 is believed to have 
a dual role in the regulation of ROS and oxidative stress homeostasis [Armata et al., 
2010]. They believed that p53 had a twofold role in maintaining ROS. They argued that the 
same pathologies related to p53 activation also induced its phosphorylation at Ser15, 
which is known as the ATM phosphorylation site. Some of these pathologies include 
atherosclerosis, hypoxia and shear stress [Armata et al., 2010]. Armata and colleagues 
(2010) first suggested a link between p53 and glucose homeostasis in 2010. They 
furthermore described the role of p53 in regulating the expression of GLUT-1 and -4 by 
cancer cells. It is believed that animals deficient in p53 protein are more susceptible to 
developing type 1 diabetes in a streptozotocin-induced model compared to control 
animals. Using this information, and the fact that AT patients display symptoms of type 2 
diabetes, they investigated the effect p53 had on the glucose homeostasis and insulin 
resistance by exploring the PKB/Akt activation in both wild type and ATM phosphorylation 
site absent p53 mice models (p53S18A) [Armata et al., 2010].  In addition, their study 
compared the expression of the naturally occurring antioxidant Sestrin and the amount of 
ROS produced by the different models. They concluded that the p53 ATM phosphorylation 
site has a defensive role in maintaining glucose levels, as they observed a higher rate of 
glucose intolerance, insulin resistance and ROS in the p53S18A models. They also 
concluded that the ATM phosphorylation site on p53 is necessary for p53-antioxidant 
dependent gene expression [Armata et al., 2010].  
S. Ditch and T.T. Paull (2012) hypothesized that the ATM protein and p53 may be working 
together to maintain glucose homeostasis. They ascribed this to an observed increase in 
ROS levels as a result of a deficit in the ATM phosphorylation sites on the p53 protein 
(Ser15). An increase in ROS leads to an increase in glucose intolerance and insulin 
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resistance, often also leading to the development of type 2 diabetes and a decrease in 
functional antioxidant activity mediated by p53. Concerning this, theoretically in the 
absence of ATM and p53 phosphorylation, the insulin-signalling pathway is undoubtedly 
disrupted [Ditch and Paull, 2012].  
 
2.3.5. Pathologies associated with increased ROS production 
Neuro-degeneration, Parkinson’s disease and Alzheimer’s disease are associated with 
oxidative stress [Marinoglou, 2012] but a discussion of these pathologies falls outside the 
scope of this thesis.   
It was found that, when the ATM protein is inactive, there is a mutation in the GLUT1 ATM 
activation site (S490 from alanine to aspartate) coupled to a decrease in ROS production. 
This is explained by an increased activation of GLUT1 in the absence of ATM. GLUT1 
takes up glucose (glucose-6-phosphate) and dehydroascorbic acid (DHA) into the cells. 
Glucose-6-phosphate and DHA both contribute electrons to antioxidant pathways 
[Andrisse et al., 2014]. These observations are absent with GLUT4 as, unlike GLUT1, it 
does not have and ATM activation site. 
 
2.4. ATM in the cytoplasm 
2.4.1. Protein translation 
As mentioned above, it has been established that the ATM protein is present in both the 
nucleus and the mitochondria. The nuclear function of ATM has been closely linked to the 
DNA damage response and the mitochondrial function of ATM has been linked to 
combating effects of oxidative stress. In addition to this, Yang and Kastan (2000) 
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described the cytoplasmic function of ATM as being a direct mediator of protein translation 
in response to insulin treatment. The eukaryotic initiation factor 4E (eIF-4E) protein carries 
out protein translation in a rapamycin insensitive manner and in the presence of insulin. In 
the inactive state eIF-4E is bound to 4E-binding protein 1 (4E-BP1). 4E-BP1 is a protein 
phosphorylated by ATM at its Ser111 phosphorylation site [Yang and Kastan, 2000]. The 
mammalian target of rapamycin (mTOR), which is a part of the ATM related kinase (figure 
2.9) can also activate 4E-BP1, [Gingras et al., 1998 and Greiwe et al., 2001]. Ser111 has a 
glutamine next to it, which is consistent with the target phosphorylation sites of ATM. 
According to Yang and Kastan (2000) 4E-BP1 has three different phosphorylation sites 
that can be activated by many different stimulators. One of them is mTOR, which is 
rapamycin sensitive, but only Ser111 is phosphorylated by the ATM protein. 
Phosphorylation of 4E-BP1 at Ser111 was confirmed when Yang and Kastan studied the 
phosphorylation of 4E-BP1 and initiation of protein translation by eIF-4E in cell cultures 
with an inactive ATM protein. In their study 293T cells, A38 (ATM-/-) and A29 (ATM+/+) 
cells were used. Additionally, Yang and Kastan (2000) sought to silence the Atm gene in 
cells expressing functional ATM or to insert a vector containing the functional Atm gene to 
reverse the lack of ATM activity as a way to confirm their previous results [Yang and 
Kastan, 2000]. 
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Figure 2.9: Cap dependent protein translation by eIF-4E. The ATM protein phosphorylates 
4E-BP1 at Ser111, which then dissociates from eIF-4E. Free eIF-4E binds to eIF-4G and 
initiates protein translation [Yang and Kastan, 2000]. 
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2.4.2. The impact of the expression and activation of ATM on insulin growth 
factor-1 and insulin receptor substrate-1 
The mTOR protein is the catalytic subunit for both mTOR-containing multiprotein complex-
1 (MTORC1) and mTOR-containing multiportein complex-2 (MTORC2), also known as the 
mTOR complex. Both mTORC1 and mTORC2 have four subunits but each complex has 
its own function. mTORC1 is responsible for protein translation whereas mTORC2 is 
responsible for cell survival [Zhang, D. et al., 2010]. Proteins targeted by mTORC1 include 
4E-BP1 and 70-kDa ribosomal protein S6 kinase (p70 S6 kinase; figure 2.10). 
Ching et al. (2013) investigated the significance of ATM protein expression in relation to 
the phosphorylation and activation of p70 S6 kinase (S6K) mediated by the insulin 
receptor substrate-1 receptor (IRS-1R) proposing that a different pathway could be 
available to activates S6K [Ching et al., 2013]. Ching et al. (2013) used both a cell culture 
model (C2C12 myotubes) and an animal model for their research. The cell culture was 
treated with short hairpin RNA (shRNA) or Ku-55933, an ATM inhibitor. The animal model 
was an ATM protein heterozygous mouse model fed a high-fat diet. Both the cell culture 
model and the animal model had age-matched controls. The C2C12 myotubes treated with 
shRNA expressed 22% of the total ATM observed in the control C2C12 myotubes. This 
value emulated the same amount of total ATM expressed in mice fed a high-fat diet 
compared to mice that were chow-fed [Ching et al., 2013]. Following this observation, 
Ching et al. (2013) found an increase in ATM phosphorylation at Ser1981 by IGF-1 after 
insulin treatment in the wild type mice (ATM+/+) but not the ATM+/- mice. IGF-1 is known 
to phosphorylate PKB/Akt in response to insulin but this signal transduction was down 
regulated in ATM+/- mice despite the fact that the total PKB/Akt expressed were the same 
in both mice models (control and high-fat fed mice), [Ching et al., 2013]. Secondly, there 
were no differences in the phosphorylation of IRS-1 by IGF-1 in heterozygous mice but a 
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decrease in the activation of PI3-K by IGF-1 in ATM+/- mice occurred. Lastly, changes in 
the phosphorylation of S6K were observed. IGF-1 activates S6K, which is a target protein 
of mTORC1. Inactive mTORC1 can be found in a complex with mTORC2. The 
phosphorylation of S6K was lower in ATM+/- C2C12 myotubes treated with shRNA. 
C2C12 myotubes treated with Ku-55933 also had less activation of S6K by IGF-1, the 
same effect was observed in the soleus of ATM+/- mice [Ching et al., 2013].  Furthermore 
Ching et al. (2013) concluded that, when ATM is inhibited or in ATM+/- mice, the activity of 
mTOR decreases. The data implies that if IGF-1 is activated by insulin then the ATM 
protein will fully mediate the activation of PKB/Akt. Since PKB/Akt can also be activated by 
other stimuli, Ching et al. (2013) concluded that the role of ATM to fully mediate PK/Akt 
phosphorylation in and ATM+/- mouse model is abolished. Based on the results obtained 
during their investigation, Ching et al. (2013) also concluded that ATM is  distal from IRS-1 
as this protein continued to be phosphorylated by IGF-1 while phosphorylation of PKB/Akt 
was reduced [Ching et al., 2013].  
Peretz et al. (2001) explored the difference in insulin-like growth factor-1 receptor (IGF-1R) 
expression among three different ATM cell lines (ATM+/+, ATM+/- and ATM-/-). They 
observed a reduction in the expression of IGF-1R in ATM -/- cell lines compared to the 
heterozygous and wild type cells (ATM+/- and ATM+/+). They also observed that IGF-1R 
played a key role in regulating apoptosis induced by cytotoxic factors, including ionizing 
radiation [Peretz et al., 2001]. The lack of resistance towards ionizing radiation in ATM-/- 
cell lines were tested by transfecting ATM-/- with a cDNA encoding for IGF-1R and 
exposing these cells as well as ATM+/- and ATM+/+ to different doses of ionizing radiation 
(1 Gy to 5 Gy). Contrary to these experiments, they also inhibited the function of the IGF-
1R with anti-IGF-IR antibody in ATM-/- cells previously transfected with the IGF-1R vector 
cDNA and found an increase in ionizing radiation sensitivity in these cells [Peretz et al., 
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2001]. Thereby, concluding that IGF-1 expression is necessary for an ATM-/- cell to 
display resistance towards ionizing radiation. 
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Figure 2.10: mTOR mediated protein translation. The mTOR protein can be activated in an 
insulin dependent manner or independent of insulin by amino acids such as leucine 
[Greiwe et al., 2001]. The mTOR protein phosphorylates both eIF-4E and S6K, thereby 
activating protein translation. mTOR activty is inhibited by rapamycin. 
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2.4.3. The role of ATM in the glucose uptake pathway and insulin resistance 
As mentioned, one of the cytosolic functions of ATM includes the phosphorylation of 4E-
BP1 in response to insulin treatment. Another function of the ATM protein in the cytoplasm 
includes facilitating glucose uptake in skeletal muscle. The protein PKB/Akt mediates both 
protein translation and glucose uptake. Insulin has proven to be a definite activator of ATM 
in the absence of DNA damage and oxidative stress (figure 2.11).  
Various research groups have studied the localization of ATM in the cytoplasm, especially 
in the development of insulin resistance. In this regard, Halaby et al., (2008) has 
researched the role of the ATM protein in rats with high-fat diet induced insulin resistance 
[Halaby et al., 2008]. 
In the study completed by Halaby et al. (2008) they investigated the expression of the ATM 
protein and its impact on the expression and phosphorylation of PKB/Akt as well as the 
possible role of ATM in the glucose uptake pathway  [Halaby et al., 2008]. Experiments 
were completed in both ATM+/+ (A29) and ATM-/- (A38) cell lines to determine if the 
presence or absence of ATM had an effect on PKB/Akt expression and activation. 
Secondly, the difference in phosphorylation of PKB/Akt by ATM in the skeletal muscle of 
rats that were insulin resistant due to being fed a high-fat diet versus chow-fed rats was 
determined. Lastly, L6 muscle cells were treated with the ATM inhibitor with or without the 
addition of insulin to determine any differences in the phosphorylation of PKB/Akt and 
GLUT4 translocation. Additionally, proteins such as IRS-1 and its phosphorylation at 
tyrosine 612 were determined in cells with or without functional ATM that were either 
treated with insulin or not. Their data indicated that a lack of ATM activity was associated 
with a decrease in PKB/Akt phosphorylation. This decrease could not be accounted for by 
the lack of PKB/Akt expression as total PKB/Akt remained uniform throughout the different 
tissue types (skeletal muscle from insulin resistant rats compared to control rats, ATM+/+ 
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and ATM-/- as well as L6 muscle cells), [Halaby et al., 2008]. Secondly, the ATM protein is 
required to phosphorylate PKB/Akt in response to insulin at Ser473 and phosphorylation of 
Ser473 is required for the phosphorylation of Thr308. There was no difference in the 
expression of both the insulin receptor and IRS-1 and no differences were observed in the 
phosphorylation of IRS-1 when treated with insulin in both the ATM+/+ and ATM -/- cell 
lines. Furthermore, it was observed that the ATM protein was necessary for the 
translocation of GLUT4 to the plasma membrane as inactive ATM resulted in a decrease 
in GLUT4 translocation, which can be associated with insulin resistance and glucose 
intolerance. Halaby et al. (2008) concluded that although the ATM protein is necessary for 
PKB/Akt phosphorylation in response to insulin, there are still uncertainties as to whether 
the ATM protein works parallel to the PI3-K and is activated by the IRS-1 or if it is the PI3-
K protein as is 4E-BP1, a known substrate of both ATM and PI3-K in the presence of 
insulin [Halaby et al., 2008]. 
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Figure 2.11: Activators of the ATM protein [Ditch and Paull, 2012]. The diagram shows the 
three known activators (DNA damage response (DDR), reactive oxygen species (ROS) 
and insulin) of the ATM protein and the different signalling pathways ATM is involved in. 
Each pathway has been assigned a colour (DDR: black, insulin: blue and ROS: red) to 
depict how ATM  responds to the different stimuli.  
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2.4.4. Inhibitors of ATM 
There are two known ATM inhibitors present on the market namely, Ku55933 and Ku-
60019 (figure 2.12). Many  research projects involving the ATM protein have used the 
ATM inhibitor Ku-55933. Ku-60019 is an ATM inhibitor, which has a higher specificity for 
the ATM protein and to date only one article is available whereby researchers have used 
Ku-60019 to test the importance of the ATM protein in Glioma cells [Golding et al., 2009]. 
Presently the only known differences between Ku-55933 and Ku-60019  is the variation in 
IC50 and Ki for Ku-55933 has an IC50 of 13 nM and a Ki of 2.2 nM [Hickson et al., 2004].  
and the solubility and IC50 of the Ku-60019 inhibitor as it is a more water-soluble 
substance, has an IC50 of 6.3 nM, and has been found to be a more potent inhibitor of the 
ATM protein than Ku-55933 [Golding et al., 2009].  
Wortmannin is a non-specific PI3-K inhibitor, which targets many of the PI3-K related 
kinases (PIKK), [Hickson et al., 2004]. Considering ATM is a part of the PIKK family it has 
been proposed that treatment with this inhibitor will abolish the function of ATM in the 
cytoplasm. 
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Figure 2.12: Diagram of ATM inhibitors Ku-60019 and Ku-55933, respectively [Golding et 
al., 2009].  
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2.5. Motivation 
As mentioned previously, few studies have been performed to establish the role of the 
ATM protein in endothelial dysfunction and cardiovascular disease. In this literature 
review, it was established that the ATM protein is a key player in the DDR in the nucleus 
and that it is a sensor for oxidative stress in the mitochondria. Recently it has been proven 
that the ATM protein localized in the cytoplasm, also plays a role in protein translation and 
in the development of insulin resistance in AT patients.  
Concerning atherosclerosis development and associated endothelial dysfunction, some of 
the common causes for these conditions include insulin resistance, hyperglycaemia, 
inflammation, oxidative stress and damaged DNA that cannot be repaired, leading to cell 
death by apoptosis. In a functional endothelial cell, the enzyme eNOS releases NO in 
order to maintain vascular homeostasis. In endothelial cells, insulin-induced activation of 
PKB/Akt is a major upstream activator of eNOS. 
Currently, there is conflicting data as to whether the ATM protein mediates the full 
activation of PKB/Akt by phosphorylating both Ser473 and Thr308 or if ATM only activates 
Ser473 [Ching et al., 2013]. Conversely, Golding et al. (2009), believes that ATM does not 
directly activate PKB/Akt. As PKB/Akt does not have the conserved serine/threonine 
phosphorylation site, which is followed by the amino acid glutamine at targeted positions 
the ATM phosphorylates in other proteins [Golding et al., 2009].  
Miles et al., (2007) believes that AT patients display normal sensitivity towards insulin but 
upon undergoing an oral glucose tolerance test they observed fleeting hyperglycaemia. 
Miles et al. (2007) ascribed this observation to ATM-/- cells having a delayed reaction in 
releasing insulin in response to glucose [Miles et al., 2007]. The delayed reaction of AT 
cells in response to glucose stimulation of insulin secretion is arguably a result of 
dysfunctional or a lack of pancreatic beta cells.  
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If ATM-/- mice have diminished functional pancreatic beta cells and thus cannot release 
insulin, there would be a decrease in PKB/Akt phosphorylation. However, if ATM-/- cells 
such as the A38 cell line are treated with insulin in vitro it has been observed that the 
activation of both IGF-1 and IRS-1 remains constant among ATM wild type and ATM null 
cells. The PKB/Akt protein is downstream from both IGF-1 and IRS-1 and thereby its 
activation is based on the phosphorylation of these two proteins in healthy cells. Ching et 
al. (2013) argued that if both IGF-1 and IRS-1 are activated by insulin in ATM-/- cells, then 
the ATM protein could be found downstream to these proteins in the signalling pathway.  
Hypothetically ATM is responsible for PKB/Akt phosphorylation at Ser473 and thus if there 
is no active ATM PKB/Akt cannot be activated. Furthermore, when a decrease in PKB/Akt 
phosphorylation occurs there will be a decrease in eNOS activation leading to a decrease 
in NO bioavailability and a disruption in vascular homeostasis as well as a decrease in 
glucose uptake resulting in hyperglycaemia. 
Contrary to these explanations Yang and Kastan (2000) and Halaby et al. (2008) both 
concluded that the ATM protein may participate in signalling pathway which is activated by 
insulin but works parallel to the PI3-K signalling pathway. Therefore, for the purpose of this 
study, the position of the ATM protein in the PI3-K signalling pathway and the effect that 
ATM expression on glucose uptake and eNOS activation will be investigated. 
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2.6. Aims and objectives 
Based on the literature review and the current motivation of the study; the aims and 
objectives of this research project are listed below. 
 
Aim 1: 
Identify a suitable model for the isolation and harvesting of AECs from male Wistar rats. 
The chosen isolation model will be determined by the following criteria: (i) highest possible 
yield of primary AECs; (ii) highest possible endothelial cell purity as measured by cell 
morphological appearance, positive staining with an endothelial cell-specific probe and 
detection of eNOS expression. 
 
Aim 2: 
Determine the difference in ATM protein expression by AECs in response to treatment with 
insulin, the ATM inhibitor Ku-60019 and the PI3-K signalling pathway inhibitor wortmannin. 
 
Objectives for aim two includes: 
Measuring the viability of the AECs after treatment with insulin, Ku-60019 and wortmannin. 
Detecting any changes insulin, Ku-60019 and wortmannin may exert on the production of 
NO by the AECs. 
Determining the role of ATM in the glucose uptake pathway and establishing a relationship 
between the ATM protein and the function of eNOS in the AECs. 
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Chapter 3: Methods  
3.1. Aortic endothelial cell (AEC) isolation techniques: 
3.1.1. Vascular ring method adapted from the article published by Hu et al., 
(2009) 
Two male Wistar rats were anaesthetized with 160 mg/kg sodium pentobarbital (Bayer 
Healthcare, Leverkusen, Germany). The rats were sprayed from head to toe with 70% 
ethanol to ensure sterility before being placed in the laminar flow chamber.  When deep 
anaesthesia, as confirmed by an absent foot pinch response, was achieved, the mid-
section of the thoracic-abdominal region was opened by incision, and the thoracic region 
of the aorta was excised. The peri-vascular fat and connective tissue were removed and 
the aortas were placed in Dulbecco’s Modified Eagle Medium (DMEM; Lonza, Basel, 
Switzerland) supplemented with fetal bovine serum (FBS; Highveld Biological, RSA). The 
full composition of the media consisted of 79% DMEM, 20% FBS and 1% penicillin-
streptomycin (Gibco, CA, USA). Using a suture, the aortas were inverted to expose the 
endothelium. The aortas were cut into rings of 2-3 mm in length. The aortic rings were 
placed in a petri dish (previously coated with attachment factor (Gibco, CA, USA) for 
1 hour) and incubated in DMEM under standard conditions (37˚C, 5% CO2, 40-60% 
humidified). The aortic rings were removed on Day 4. Cells that have detached from the 
aortic rings onto the petri dish were allowed to grow until confluency and received fresh 
endothelial cell basal medium-2 (EGM-2MV; Lonza, MD, USA) supplemented with 20% 
FBS every two days (figure 3.1).  
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Figure 3.1: Diagram of the protocol used in the vascular ring method. 
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3.1.2. Collagenase method (adapted from the article by Kobayashi et al., 
2005) 
Three male Wistar rats were anaesthetized with sodium pentobarbital (160 mg/kg) and 
sacrificed by exanguination when deep anaesthesia, as indicated by the lack of response 
on a foot pinch, was reached. The animals were sprayed with 70% ethanol to sterilize 
them before placing their bodies in the laminar flow chamber. The aortas were cut above 
the left renal artery to release the blood.  Heparin Sodium – Fresenius (5000 i.u./ml, 
Bodene (PTY) Limited trading as Intramed, PE, South Africa) was diluted in PBS (137 mM 
NaCl, 2.68 mM KCl, 8.33 mM Na2HPO4 and 1.47 mM KH2PO4) to obtain a final 
concentration of 1000 i.u./ml. The Heparin PBS mixture was injected into the left ventricle 
of the heart to rinse the aorta. The portion of the aorta extending from the aortic arch to the 
renal artery was removed and placed in DMEM solution (DMEM + 1% penicillin-
streptomycin + 20% FBS). The aorta was washed with 0.2 ml Heparin-PBS followed by a 
second wash step with 0.2 ml serum free DMEM. The abdominal region of the aorta was 
trimmed off, along with the aortic arch. The aorta was then bound to a 26 gauge needle 
and its distal end tied closed with a silk thread. The lumen was filled with a 0.3 g/ml 
collagenase solution (Worthington Type 2, Biochemical Corporation, NJ, USA) and 
incubated under standard conditions as described for the vascular ring method, for 45 
minutes (figure 3.2). Thereafter the lumen was washed with 5 ml DMEM solution (DMEM + 
1% penicillin-streptomycin + 20% FBS) and the effluent captured in a 15 ml conical tube. 
Following this, the contents of the tubes were centrifuged at 1200 rpm, 4˚C for 5 minutes. 
The supernatant was aspirated and the pellet re-suspended in 2 ml DMEM solution 
(DMEM + 1% Pen-Strep + 20% FBS) and plated in a 35 mm petri dish previously coated 
with attachment factor for 1 hour. The cells were incubated under standard conditions. 
After 2 hours the media was removed and the cells were given EGM-2MV growth medium 
supplemented with 20% FBS. The cells received fresh growth medium 24 hours after the 
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initial isolation and allowed to grow freely. At day six post-AEC isolation, the AECs were 
detached with trypsin (2.5%  Trypsin-EDTA diluted 10x in sterile PBS; Invitrogen, CA, 
USA) and re-seeded on a single 35 mm petri dish and once again allowed to grow until 
confluency. Once the cells reached confluency they were trypsinized and passaged in a 
1:2 ratio, to the next generation. All cells were used at generation four to six for 
experimental purposes. 
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Figure 3.2: Isolated male Wistar rat thoracic aortas being bound to a 26-guage needle (A) and its distal end ligated 
closed using a silk thread (B).  (C) Thoracic aortas containing collagenase solution in the lumen prior to incubation at 
standard condition for 45 minutes. 
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3.1.3. Validation of endothelial cell purity: Acetylated low density lipoprotein 
(Ac-LDL) 
1,1’-dioctadecyl-3,3,3’,3’-tetramethylindo-carbocyanine perchlorate (Dil) is a fluorescent 
probe attached to LDL after it has been acetylated. Dil-Ac-LDL (Biomedical Technology 
Inc., MA, USA) is an endothelial-specific marker used to stain endothelial cells in order to 
measure the purity of the culture. 
Dil-Ac-LDL (50 µl) was added to 950 µl AEC media for a final concentration of 10 µg/ml 
according to the suppliers’ instructions. The cells were washed twice with 2 ml sterile 
phosphate buffer saline (PBS) and incubated in 1 ml Dil-Ac-LDL/ EGM-2MV growth 
medium for 4 hours under standard conditions. After 4 hours, the cells were trypsinized 
and centrifuged at 1000 rpm, 4˚C for 3 minutes. The supernatant was aspirated and the 
pellet re-suspended in 750 µl PBS. Positive staining of the cells with Dil-Ac-LDL was 
observed by fluorescence microscopy or flow cytometric analysis (FACS Calibur- Becton 
Dickinson; BD Biosciences, CA, USA). Data were expressed as the % cells that stained 
positively with the probe compared to unstained control cells. 
3.2. Western blots 
i. Lysis buffer 
20.0 mM Tris-HCl (pH 7.5), 1.0 mM EGTA, 1.0 mM EDTA, 150 mM NaCl, 1.0 mM β-
glycerophosphate, 2.5 mM sodium pyrophosphate, 0.1% sodium dodecyl sulfate (SDS), 
1.0 mM sodium orthovanadate (Na3VO4), 1.0% Triton X-100, 10 µg/ml Leupeptin, 10 µg/ml 
Aprotinin, 50 nM sodium fluoride (NaF) and 50 µg/ml Phenylmethanesulfonyl Fluoride 
(PMSF). 
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ii. The growth medium was aspirated and AECs were washed twice with sterile PBS. The 
AECs were trypsinized with 0.25% trypsin as described earlier. The AECs from five 
35 mm petri dishes were pooled into one 15 ml conical tube with 2 ml AEC media 
(AEC media supplemented with FBS) to prevent any further trypsin enzyme activity. 
The cells were centrifuged at 1000 rpm, 4˚C for 3 minutes. The supernatant was 
aspirated and the pellet re-suspended in EGM-2MV growth medium. The re-
suspended AECs were transferred to a 1.5 ml Eppendorf tube and subjected to further 
centrifugation at 1000 rpm, 4˚C for 3 minutes. The supernatant was once again 
aspirated and zirconium oxide beads (0.5 mm diameter) were added to the pellet in a 
1:1 ratio. Additionally, 800 µl of lysis buffer was added to the mixture. The sample was 
homogenized at 4˚C using a bullet blenderTM (Next Advance) for three cycles of 
1 minute with a 5 minute rest period in between. Thereafter the samples were 
incubated on ice for 20 minutes. Following this, the samples were centrifuged at 
14 000 rpm for 20 minutes at 4˚C. The supernatant was transferred to another marked 
Eppendorf tube and stored on ice until further use, while the pellet was discarded. The 
amount of protein available in each sample was determined according to the method 
of Bradford (M. Bradford, 1976). Bovine serum albumin (BSA; Roche, Mannheim, 
Germany) was used to generate a standard curve of known concentrations. All 
samples were diluted 10-fold with distilled water in order to dilute the detergents in the 
lysis buffer as they will interfere with the Bradford method. Aliquots of the diluted 
sample were made up to 100ul with distilled water and assayed in duplicate to verify 
results. Double filtered Bradford reagent (900 µl) was added to both the standard 
curve and the protein samples, vortexed and incubated at room temperature for 
15 minutes. The absorbance values were read at 595 nm. Once the protein 
concentrations of the samples have been obtained, protein lysates were brought to the 
same amount of protein per volume unit by addition of lysis buffer and Laemmli 
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sample buffer. The lysates were boiled for 5 min and stored away at -80˚C until further 
use.  
 
iii. Protein lysates were loaded into a 4% stacking gel and separated on various 
percentage SDS-PAGE gels (Table 3.1). The SDS-PAGE gels were electrophoresed 
for 10 minutes at 100 V and 200 mA, followed by a second round of electrophoresis for 
50 minutes at 200 V and 200 mA. The running buffer consisted of 25 mM Tris-Base, 
192 mM Glycine and 0.1% SDS. All protein lysates were prepared as described 
above. Proteins involved in the insulin signalling pathway mediating glucose uptake 
were probed for (Table 3.2).  
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Table 3.1: The table below consist of a list of different SDS-PAGE gels used and their 
respective compositions. 
Reagent Stock 7.5% 10% 12% 4% (stack gel) 
dH2O Distilled 5.525 ml 4.9 ml 3.35 ml 3.05 ml 
Tris (pH 8.8) 1.5 M 2.5 ml 2.5 ml 2.5 ml  
Tris (pH 6.8) 0.5 M    1.25 ml 
SDS 10% 100 µl 100 µl 100 µl 50 µl 
Acrylamide 40% 1.875 ml 2.5 ml 3.0 ml 0.5 ml 
APS 10% 50 µl 50 µl 50 µl 50 µl 
TEMED 99% 20 µl 20 µl 20 µl 10 µl 
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iv. List of antibodies and their suppliers: 
Cell Signaling (MA, USA): Antibodies used in this research thesis: eNOS, phospho-eNOS 
(Ser1177), PKB/Akt, phospho-PKB/Akt (Ser473), ATM, phospho-ATM (Ser1981), AMPK, 
phospho-AMPK (Ser172), PI3-K/P85, phospho-PI3-K/P85 (Y458/p55), PTEN, phospho-
PTEN (S380/T382), AS160, phospho-AS160 (Ser588), GSK3β and phospho-GSK3β 
(Ser9). 
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Table 3.2: Proteins probed in this research project are listed below along with their 
molecular weights (kDa) and optimization conditions  
Protein 
Phospho 
Site 
MW Gel % 1˚ Ab dilution 2˚ Ab dilution 
eNOS Ser1177 140 7.5 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
PKB 
 
Ser473 60 10 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
ATM 
 
Ser1981 350 4-15% 
gradient gel 
1:1000 in 
signal boost 
1:4000 in signal 
boost 
AMPK Ser172 62 10 1:1000 in 2.5% 
TBS-Tween 
milk 
1:4000 in 2.5% TBS-
Tween milk 
P85-
PI3-K 
Y458/p55 85 10 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
PTEN S380/T382 54 10 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
AS160 Ser588 160 7.5 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
GSK3β Ser9 46 12 1:1000 TBS-
Tween 
1:4000 TBS-Tween 
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v. All proteins besides ATM were transferred to ImmobilonTM PVDF membranes for 
60 minutes at 200 V and 200 mA using a transfer buffer containing 25.0 mM Tris-
Base, 192 mM Glycine and 20% (v/v) methanol. 
vi. The ATM protein was transferred to ImmobilonTM PVDF membranes for 90 minutes at 
200 V and 200 mA using transfer buffer containing 25.0 mM Tris-Base, 192 mM 
Glycine and 10% (v/v) methanol. 
The longer transfer time and less methanol used in the transfer buffer were used to 
ensure the capture of larger proteins like ATM which is 350 kDa. 
vii. After transfer, the membranes were washed in methanol and left to air-dry to assist 
binding of protein to the membranes.  The dry membranes were stained with Ponceau-
Red reversible stain to monitor adequate transfer of proteins and verify equal loading. 
viii. After removing the Ponceau-Red stain, the membranes were washed thoroughly three 
times with TBS-Tween (Tris-buffered saline containing 0.1% Tween-20) and blocked in 
TBS-Tween containing 5% fat free milk powder for 90 minutes. Thereafter the 
membrane was once again washed thoroughly with TBS-tween and incubated at 4oC 
in the respective primary antibodies overnight.  
ix. After the overnight incubation, the membranes were washed three times with TBS-
Tween, followed by 60 minute incubation at room temperature in the appropriate 
secondary antibody linked to horse-radish peroxidase (HRP), (Cell Signaling, MA, 
USA). 
x. After exposure to the HRP-linked secondary antibody, the membranes were washed 
three times with TBS-Tween and treated to Clarity Western ECL (Bio-Rad, CA, USA) 
prior to exposure to Amersham Hyperfilm to capture the chemiluminescent light 
emmision. 
xi. Membranes were prepared as mentioned in (ix) above using the ChemiDocTM.( Bio-
Rad, CA, USA). The ChemiDoc is sensitive to the proteins being exposed as it allows 
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one to either pick up intense bands (protein bands which are quite prominent and are 
exposed within seconds) without over exposing the membrane and obtains a more 
crisp image and it can pick up faint bands easily (bands which are difficult to pick up 
using the Amersham Hyperfilm or bands that will take longer to expose, often the case 
with phosphorylated proteins).  
xii. The film was subjected to laser-scanning and densitometry using suitable software 
(UN-SCAN-IT, Silkscience, USA) to analyze the intensity of the bands in pixels. 
 
3.3. Commercial Aortic endothelial cells (AECs) 
Adult rat AECs were commercially purchased from VEC technologies (NY, USA) and 
delivered in 75 ml tissue culture flasks coated with fibronectin. The AECs were cultured in 
endothelial cell basal medium-2 (EGM-2MV) until confluent, later supplemented with 10% 
FBS. Once confluent the cells were trypsinized and centrifuged at 1000 rpm, 4˚C for 3 
minutes. The supernatant was aspirated and the pellets were collected and stored away 
for future use. The cell pellets were stored in a cryo-vial containing a solution made up of 
90% FBS, 5% AEC media and 5% DMSO (Figure 3.3). The cell suspension was stored in 
liquid nitrogen until needed. The commercially purchased AECs were subjected to staining 
with Dil-Ac-LDL to measure the purity of the cells in culture. AECs were considered a pure 
culture when more than 80% of the total cell population stained positively with Dil-Ac-LDL. 
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Figure 3.3: Diagram depicting the procedure used to passage and label the cells [Genis, 
A., 2014]. 
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3.4. AEC treatment groups: 
3.4.1. Insulin dose response curve: 
The AECs were washed twice with sterile PBS. Afterwards the AECs were serum starved 
by incubating them for 15 min at physiological conditions with sterile PBS. The PBS was 
aspirated and the cells were washed once with fresh PBS. The AECs were separated into 
three treatment groups which included a control, baseline group (treated with PBS), a 
10 nM and a 100 nM insulin (Sigma-Aldrich, MO, USA) group. The insulin was prepared by 
dissolving the Zinc (anhydrous) insulin powder in 10mM HEPES buffer pH 7.4 to a final 
concentration of 10 µM before further diluting it to 10 nM and 100 nM concentrations. The 
cells were treated for 15 min under standard incubation conditions. After the treatment 
period, the AECs were washed once with PBS and lysates were prepared for western blot 
analyses as described earlier. The cells from approximately 20 randomly chosen 35mm 
petri dishes were pooled for each experimental group. Protein lysates were prepared from 
10 petri dishes, which yielded two sets of protein lysates per group.  
 
3.4.2. Stimulation and inhibition of the phosphatidylinositol-3 kinase (PI3-K) 
signalling pathway with emphasis on the ATM protein 
AECs were washed twice with PBS followed by a 15 min incubation in fresh PBS at 
physiological conditions to serum starve these cells. Afterwards the cells were washed 
once with PBS and separated into seven different treatment groups. These groups 
included a control, baseline group (PBS), 10 nM insulin, vehicle (DMSO), 3 µM KU-60019 
(Selleckchem; Texas, USA), 3 µM KU-60019 with 10 nM insulin, 100 nM wortmannin, 
100 nM wormannin with 10 nM insulin. All solutions were made up in sterile PBS. DMSO 
was used as the vehicle control because it was used to dissolve the ATM inhibitor KU-
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60019 as well as wortmannin, the PI3-K inhibitor. AECs assigned to the control, KU-
60019, DMSO and wortmannin groups were treated for 30 min, whereas the AECs 
assigned to the insulin treatment group were first incubated for 15 min in fresh PBS before 
the addition of insulin. Both the KU-60019 with insulin and the wortmannin with insulin 
groups were exposed to the respective inhibitors for 15 min before the addition of 10 nM 
insulin for a further 15 min. Following this, the cells were either used to measure the NO 
production, determine the cell viability after treatment or to make protein lysates. 
 
3.4.3. 4,5-diaminofluorescein-2/diacetate (DAF-2/DA) 
DAF-2/DA (Calbiochem, EMD Millipore Corporation, CA, USA) was used to determine NO 
production by the cells.  DAF-2/DA is a cell permeable, NO-specific fluorescent probe that 
is hydrolyzed by cytosolic esterases when it enters through the cell membrane [Strijdom et 
al., 2006]. Once in the cell, the probe traps NO in the presence of oxygen and emits a 
fluorescent signal at 515 nm [López-Figueroa et al., 2001].  
In DAF-2/DA experiments approximately three AEC petri dishes (35 mm) were assigned to 
each treatment group. Once the cells have been treated, DAF-2/DA (2µl/ml PBS) was 
added to the AECs and incubated for two hours under standard conditions. Thereafter the 
cells were trypsinized and transferred to a 15 ml conical tube containing 1 ml cell staining 
buffer. The cells were centrifuged at 1000 rpm for 3 min at 4˚C. The supernatant was 
aspirated and the pellet dissolved in 750 µl PBS before being transferred to a flow 
cytometry tube (BD Falcon, 5 ml polystyrene round bottom tube; BD Biosciences, MA, 
USA). NO production was measured using the FACS Calibur-BD (BD Biosciences, CA, 
USA) in the FL1-H channel.  An absolute control (untreated and unstained) was added to 
each experiment. It consisted of a single 35 mm petri dish with a confluent AEC culture, 
Stellenbosch University  https://scholar.sun.ac.za
74 
 
which had been treated with PBS for 30 min after the serum starvation step, but with the 
omission of DAF-2/DA. Additionally, a positive control was added to each DAF-2/DA 
experiment. In the positive control protocol, AECs were treated with DAF-2/DA for one 
hour, after which diethylamine nonoate (DEA/NO; Sigma-Aldrich, Schnelldorf, Germany), 
the NO donor, was added to the AECs and incubated for two hours. In summary, the 
AECs were incubated for three hours at standard conditions.  
 
3.4.4. Propidium iodide 
Propidium iodide (PI; Sigma-Aldrich, Schnelldorf, Germany) was used to determine the 
viability of the cells. PI cannot enter intact, healthy viable cells as it is a membrane 
impermeable probe. If a cell dies due to necrosis, it is expected that PI would be able to 
penetrate the injured cell membrane, move to the nucleus where it binds to nucleic acids, 
which produces the fluorescent signal observed in a population of non-viable cells 
[Nicoletti et al., 1991 and Al-Rubeai et al., 1997]. If a cell population is healthy there would 
be very low or no fluorescent signal.  
After treatment the AECs were trypsinized and transferred to a 15 ml conical tube 
containing 1 ml cell staining buffer. The cells were centrifuged at 1000 rpm for 3 min at 
4˚C. Thereafter the supernatant was aspirated and the pellet re-suspended in 990 µl PBS 
and transferred to a flow cytometry tube. Propidium iodide aliquots were prepared in PBS 
to obtain a stock concentration of 500 µM. Thereafter, 10 µl of the stock solution was 
added to the FACS tube containing the AECs to obtain a final concentration of 5 µM. The 
AECs were then incubated for 15 min under standard conditions. Cell viability was 
measured using the FL2-H channel on the FACS Calibur-BD. The viability of the cells was 
measured by the increase in fluorescence intensity emitted by necrotic cells.  
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3.4.5. Statistical analysis: 
All data were analyzed with GraphPad PrismTM version 5.0. Data are presented as mean ± 
standard error of the mean (SEM). A One-Way ANOVA with a Bonferroni post-test was 
used to analyze more than two groups. A Student’s t-test was used to compare two sets of 
data. A probability (p) value being less than 0.05 (p < 0.05) was considered significant. 
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Chapter 4: Isolation of aortic endothelial cells 
 
For the purpose of this research, one of the aims was to isolate and harvest a primary 
culture of vascular aortic endothelial cells (AECs). The purpose of this aim was to 
determine if it was possible to isolate and harvest primary AECs in our laboratory and use 
them for experimental research. Based on the success of the AEC isolation technique, the 
next aim would then be to isolate AECs from the thoracic region of the aorta in animals fed 
a high-fat diet to induce an insulin resistant model. 
Before isolating the AECs, extensive research was completed on the different isolation 
procedures published over the past 20-30 years. This has created a pool of different 
isolation techniques for new researchers. An extensive review of the literature has 
revealed three major endothelial cell isolation techniques, or variations thereof. The first 
technique uses collagenase to digest the matrix that keeps the endothelial cells attached 
to the SMCs [Smith, 1989; Gordon et al, 1991; Marin et al, 2001; Chen, S., et al, 2004; 
Kobayashi, M. et al, 2005; Hu et al. 2009]. The second technique also uses collagenase, 
but is coupled with scraping of the  endothelial cells away from the SMCs [Zhang, X., et al, 
2007]. The third technique consists of cutting the vascular arteries into rings and allowing 
the endothelial cells to move off the explant and onto the bottom of the petri dish 
previously treated with an extracellular matrix attachment substance [Nicosia et al, 1994; 
Kreisel et al, 2001; Magid et al, 2003; Chao et al, 2003; Hu et al. 2009]. This technique is 
aimed at separating the endothelium from the rest of the vascular wall; if successful, the 
attached cells remain behind when the vessel is removed from the petri dish after a certain 
period of time. 
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One of the biggest challenges in isolating cells for primary cultures is the risk of 
contamination by other cell types located in the same organ or tissue. When isolating ECs 
from blood vessels, the main contaminating culprits are SMCs and fibroblasts. Therefore, 
researchers have been focussing on the design of techniques aimed at maintaining a pure 
EC culture as far as possible. Magid et al, used fluorescence-actived cell sorting (FACS) 
by flow cytometry to separate endothelial cells from non-endothelial cells followed by re-
culturing while Hu et al, used serial dilution to purify the endothelial cell culture. According 
to their protocol the cells were diluted to 5 cells/ml after they were isolated and cultured in 
a 96-well plate [Magid et al, 2003; Hu et al. 2009]. For the most part researchers have 
been using acetylated low density lipoprotein (Ac-LDL) coupled to a fluorescent probe 1,1’-
dioctadecyl-1,3,3,3’,3’-tetramethyl-indocarbocyanine (Dil; Dil-Ac-LDL) to identify their cells 
as being endothelial cells [Chen, S., et al, 2004; Nicosia et al, 1994; Gordon et al, 1991; 
Magid et al, 2003, Kreisel et al., 2001] as well as using specific fluorescent antibodies to 
detect endothelial specific markers, namely: VCAM-1 and ICAM-1 [Marin et al, 2001], von 
Willebrand factor/Factor VIII [Chen, X., et al, 2013; Smith, 1989; Nicosia et al, 1994; 
Gordon et al, 1991, Magid et al, 2003], angiotensin converting enzyme (ACE), CD31 
[Chen, S., et al, 2004] and CD43 [Chen, X., 2013]. Upon the satifaction of the purity of an 
endothelial cell culture after rigorous methods to prove there are no contaminants present, 
the endothelial cells are often used between passages three and six for experimental 
purposes.  
 In this research study, two methods were identified and tested to isolate thoracic AEC. 
The first being the vascular ring method followed by the collagenase method. In this 
protocol, all buffers and equipment were autoclaved to ensure sterility; the lamina flow 
chamber was exposed to 5 min ultraviolet light before all surfaces were wiped down with 
70% ethanol. The bottom surface of the lamina flow chamber was covered in linen savers 
to capture any excess blood. Male Wistar rats were anaesthetized with 160 mg/kg sodium 
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pentobarbital. The rats were sprayed with 70% ethanol to sterilize them before placing 
them in the lamina flow chamber. Once the rats failed to respond to a foot pinch, they were 
sacrificed by exsanguination. The aorta was removed by cutting the aorta out between the 
third aortic arch to above the left kidney. The distal and the proximal ends of the aorta 
were trimmed off to remove the jagged edges. The aorta was cleaned of all perivascular 
adipose tissue (PVAT). 
 
4.1. The vascular ring method 
After the removal of PVAT the aorta was inverted using a suture and forceps. Thereafter 
the aorta was cut into rings and placed in a 35 mm petri dish previously coated with 
attachment factor and containing 2 ml Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 1% penicillin-streptomycin (Pen-Strep) and 20% fetal bovine serum 
(FBS). The aortic rings remained in culture for 4 days receiving fresh DMEM media 
containing all supplements every 2 days. This was to ensure the cells would detach from 
the aortic rings and onto the attachment factor where they would migrate and grow. On the 
sixth day after the initial isolation the cells in culture were detached with 0.25% trypsin-
EDTA and re-seeded until the cells became confluent. Thereafter the cells were stained 
with Dil-Ac-LDL for assessment of endothelial purity. Cardiac microvascular cells were 
used as a known endothelial cell control for positive staining by Dil-Ac-LDL. Cells were 
treated with 10 µg/ml Dil-Ac-LDL diluted in DMEM and incubated for 4 hours at standard 
conditions (37˚C, 5% CO2, 40-60% humidified). The excess Dil-Ac-LDL probe was washed 
away with phosphate buffer saline (PBS), the cells were trypsinized with 0.25% trypsin-
EDTA and centrifuged to collect the pellets. Each pellet was resuspended in 750 µl PBS 
and transferred to a FACS tube. The fluorescence intensity was used to measure the 
percentage the total cell population which stained positive with the probe Dil-Ac-LDL. The 
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fluorescence emitted by the cells was measured using the FACS Calibur-BD. The size 
(forward scatter) and granularity (side scatter) of the cells in culture were measured for 
10000 events (refers to the cell population measured; figure 4.1).  
In this experiment there were three sample groups namely (i) the unstained control group: 
commercially purchased endothelial cells that were not treated with Dil-Ac-LDL; (ii) positive 
control group: commercially purchased endothelial cells stained with Dil-Ac-LDL; and (iii) 
the cells isolated from the aortas (experimental group); these cells were treated with Dil-
Ac-LDL under the same conditions as the positive control group. 
The fluorescence intensity of each culture was measured with the FACS Calibur-BD, and 
analyzed with the WinMD software (Purdue University Cytometry Laboratories; IN, USA). 
The mean fluorescence intensity measurements of the commercially purchased 
endothelial cells are shown in figure 4.1. The area with the highest density (figure 4.1 A) 
on the scatterplot was gated to analyze the cell population in this area exclusively. On the 
histogram (figure 4.1 B), the unstained control cells emitted low fluorescence intensity, 
which is an indication of autofluorescence of the cells. When the cells were treated with 
Dil-Ac-LDL (positive control cells), the mean fluorescence intensity showed a significant 
right shift (figure 4.1 C), indicating a high degree of endothelial cell purity. 93 % of the cells 
in the positive control sample stained Dil-Ac-LDL, indicating that the vast majority of the 
cells in these samples were pure endothelial cells (figure 4.1 C).  
For the experimental groups (i.e. cells harvested from the aortas), it was observed that the 
cell population expressed using the scatterplot showed a greater degree of cell granularity 
(as indicated by the upward shift of the cell population; figure 4.2 B) compared to the 
commercially purchased endothelial cells (figure 4.2 A). Additionally, not all of the cells in 
the experimental samples were contained within the gated region. It was also observed 
that although there was a slight shift in the mean fluorescence to the right compared to the 
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unstained control only 0.8% of the cells in the experimental control were positively stained 
with Dil-Ac-LDL in comparison to the positive control (figure 4.3). The data present are 
indicative of four to six different experiments (n = 4 - 6). 
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Figure 4.1: Validation of the endothelial cell purity of commercially purchased AECs with 
flow cytometric analysis of fluorescence intensity after staining with the endothelial-specific 
marker, Dil-Ac-LDL. (A) Representative scatterplot of the cells with forward scatter (cell 
size) and side scatter (cell granularity) on the x-axis and y-axis respectively. The round 
circle indicates the gated population of the sample which was analysed. (B) Mean 
fluorescence intensity of an unstained control sample showing the autofluorescence of the 
cells. The horizontal line (M1) is inserted at the point of maximum fluorescence of the 
unstained control sample. (C) Mean fluorescence intensity of a sample treated with Dil-Ac-
LDL showing a clear right shift in the mean fluorescence intensity and the % cells that 
stained positively with the probe, as determined by M1, was 93% compared to the 
unstained control. 
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Figure 4.2: (A) Representative scatterplot of the commercial endothelial cells with forward 
scatter (cell size) and side scatter (cell granularity) on the x-axis and y-axis respectively. 
The round circle indicates the gated population of the sample which was analysed. (B) 
Representative scatterplot of the experimental cells with forward scatter (cell size) and 
side scatter (cell granularity) on the x-axis and y-axis respectively. 
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Figure 4.3: Validation of the endothelial cell purity by comparing the endothelial cells 
isolated from rat thoracic aorta with commercially purchased AECs with flow cytometric 
analysis of fluorescence intensity after staining with the endothelial-specific marker, Dil-Ac-
LDL.  (A) Representative histogram of the unstained commercially purchased AECs with a 
mean fluorescence between 100 and 101. (B) Mean fluorescence of the commercially 
purchased AECs stained positively with Dil-Ac-LDL compared to the unstained population. 
The horizontal line (M1) was inserted at the point of maximum fluorescence of the 
unstained control sample. (C) Mean fluorescence of the experimental cell population 
stained with Dil-Ac-LDL. The mean fluorescence was between both the unstained control 
and the positive control, 0.8% of the gated experimental cell population were stained 
positively with Dil-Ac-LDL as determined by M1. 
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4.2. Collagenase method 
After the PVAT was removed the lumen of the aorta was rinsed with 1000 I.U/ml Heparin 
diluted in PBS. Thereafter the thoracic region of the rat aorta was ligated to a 26-gauge 
needle at the proximal end and ligated closed at the distal end. The lumen was filled with 
3 mg/ml collagenase type 2 dissolved in serum free DMEM. The rat aortas filled with 
collagenase-DMEM solution were incubated under standard conditions for 45 min. 
Following this, the distal end of the aorta was cut open above the thread used to ligate the 
lumen closed. The lumen was flushed with 5 ml DMEM solution to capture the endothelial 
cells that dissociated from the vascular wall due to the enzymatic action of the collagenase 
in a 15 ml conical tube. The cell suspension was centrifuged at 1200 rpm for 5 min at 4 ˚C.  
The cell pellet was collected and resuspended in 2 ml endothelial cell growth medium 
(EGM-2 MV) supplemented with 20% FBS. The cell suspension was plated in a 35 mm 
petri dish coated with attachment factor and incubated at standard conditions. Two hours 
after the cell culture was incubated, they received fresh media. The cell culture was 
incubated for six days, receiving fresh media every two days before it was trypsinized with 
0.25% trypsin-EDTA and replated in a 35 mm petri dish until they reached confluency. 
Finally the cells were passaged every two days or when confluent. 
The purity of the endothelial cells isolated using the collagenase method, were determined 
according to three different tests. The first test was based on cell morphology, (were the 
cells isolated in the laboratory mimic normal endothelial cell in size and shape). The 
second test was based on the positive staining of these cells with Dil-Ac-LDL. Thirdly, the 
expression of the enzyme eNOS was determined.     
 
Stellenbosch University  https://scholar.sun.ac.za
85 
 
4.2.1. Cell morphology 
After the cells were isolated from the lumen of the rat aorta they were often observed to 
gather together like a bunch of  grapes and as time progressed and the cells properly 
attached to the attachment factor (a gelatine substance) on the surface of the petri dish 
and  began to migrate and multiply (figure 4.4). Cells were allowed to grow and become 
confluent before they were passaged to the next generation.  
 
4.2.2. Dil-Ac-LDL staining 
Between the 3rd and 6th generations, the cells isolated were stained with Dil-Ac-LDL to 
determine the purity of the endothelial cell culture. After the cells were stained with Dil-Ac-
LDL, they were either analysed with flow cytometry or by fluorescent microphotography to 
determine positive staining of the experimental cells. Figure 4.5 (A) represents the 
commercially purchased AECs which were used as both the unstained and the positive 
control. Most of the cells on the scatterplot (B) fell within the same region as the 
commercially purchased endothelial cells, although the experimental cells were observed 
to be slightly bigger and more granular than the commercial AECs. Once again, an 
unstained control was commercial cells that were not treated with Dil-Ac-LDL and 
autofluoresced between 100 and 101 on the log scale (figure 4.5.C). A horizontal line (M1) 
was placed on the histogram at the highest mean fluorescence of the unstained cell 
population. The commercial cells stained with Dil-Ac-LDL had a shift in mean fluorescence 
intensity to the right compared to the unstained control (Figure 4.5.D). The percentage of 
cells stained positive with Dil-Ac-LDL as determined by M1 was 97.8%. To test the purity 
of the experimental cells isolated using the collagenase method the experimental control 
was subjected to the same conditions as the positive control. In the representative 
example given in Figure 4.5.E, 84.8% of the cells of the experimental sample stained 
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positively with Dil-Ac-LDL. These results indicate high endothelial cell purity. The data 
presented in this section are representative of approximately 10 different AEC isolations. 
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Figure 4.4: Cells isolated from the lumen of the thoracic region of male Wistar rats. 
Successful isolation of the experimental cells was determined based on the presence of 
cell colonies often clumped together like a bunch of grapes. Thereafter the viability and the 
growth of the cells were documented daily until the cell culture reached confluency. The 
morphology of the cells was often shaped like a cobblestone which is a characteristic of 
vascular endothelial cells. 
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Figure 4.5: Validation of the endothelial cell purity of commercially purchased AECs and 
AECs isolated using the collagenase method with flow cytometric analysis of fluorescence 
intensity of the endothelial-specific marker, Dil-Ac-LDL. (A and B) Representative 
scatterplot of the cells with forward scatter (cell size) and side scatter (cell granularity) on 
the x-axis and y-axis respectively. The round circle indicates the gated population of the 
sample which was analysed. (C) Mean fluorescence intensity of an unstained control 
sample showing the autofluorescence of the cells. The horizontal line (M1) is inserted at 
the point of maximum fluorescence of the unstained control sample. (D) Mean 
fluorescence intensity of a sample treated with Dil-Ac-LDL showing a clear right shift in the 
mean fluorescence intensity and the % cells that stained positively with the probe, as 
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determined by M1, was 97.8% compared to the unstained control. (E) Mean fluorescence 
intensity of an experimental sample treated with Dil-Ac-LDL showing a shift to the right in 
the mean fluorescence intensity, 84.8% of the cells in the experimental sample stained 
positively with Dil-Ac-LDL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
90 
 
4.2.3. Cell cultures stained with Dil-Ac-LDL: Microphotographic analysis 
Photographic images were taken of the experimental cells in culture.  First images were 
taken of endothelial cells cultured in a 35 mm petri dish (figure 4.6). The cells were stained 
with Dil-Ac-LDL for 4 hours under standard conditions. Pictures were taken with a Nikon 
LDM camera (Nikon; Tokyo, Japan) in the Department of Biomedical Sciences, 
Stellenbosch University. The Dil-Ac-LDL staining was analysed with a red filter, and the 
magnification was set at 10x objective. In separate analyses, images were taken at the 
Central Analytical Facility (CAF), Stellenbosch University. Endothelial cells were grown in 
a Borosilicate coverglass system (Nunc, NY, USA). The “Carl Zeiss Confocal LSM 780 
Elyra S1 with SR-SIM super resolution platform” microscope (Carl Zeiss, Jena, Germany) 
was used to photograph the cells stained positively with Dil-Ac-LDL. Images were taken at 
a magnification of 60 (figures 4.7, 4.8 and 4.9). Images were taken of the same sample 
area with and without the background. Figures 4.7 and 4.8 are of the experimental cells 
isolated using the collagenase method and the cells in figure 4.9 are commercially 
purchased AECs (the colour of the fluorescence was changed to differentiate between the 
two different cell types). In figure 4.7 the big bold patches of red is the Dil-Ac-LDL that was 
unable to stain cells and could not be washed away properly with PBS. The red 
fluorescence at a lower intensity in cells which have been successfully stained with the 
probe. In figure 4.8 cells were stained with Dil-Ac-LDL but it was also observed that there 
were other cell types contaminating the cell culture, as they did not fluoresce. Figure 4.9 
are commercial AECs stained with Dil-Ac-LDL. The Dil-Ac-LDL is the ring structure in the 
centre of the cells surrounding the nucleus. As can be seen, all the cells present in this 
image are stained positively with the probe. 
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Figure 4.6: Isolated endothelial cells in culture after being stained with Dil-Ac-LDL.  The 
image was taken using a Nikon LDM fluorescent camera. 
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Figure 4.7: AECs (experimental control) were cultured in an eight chamber borosilicate 
coverglass system (Nunc, NY, USA) stained with Dil-Ac-LDL, the bar is 10 µm and the 
magnification 60x. AECs were isolated using the collagenase method. Images were taken 
with a Carl Zeiss Confocal (LSM 780 Elyra S1 with SR-SIM super resolution platform) 
microscope (Carl Zeiss, Jena, Germany). The concentration of the probe used was 
10 µg/ml Dil-Ac-LDL. 
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Figure 4.8: Cells stained with Dil-Ac-LDL, 60x magnification. AECs (experimental control) 
were cultured in an eight chamber borosilicate coverglass system and stained with Dil-Ac-
LDL, the bar is 10 µm. AECs were isolated using the collagenase method. Images were 
taken with a Carl Zeiss Confocal (LSM 780 Elyra S1 with SR-SIM super resolution 
platform) microscope. The concentration of the probe used was 10 µg/ml Dil-Ac-LDL. 
Stellenbosch University  https://scholar.sun.ac.za
94 
 
 
Figure 4.9: Commercial AECs stained with Dil-Ac-LDL, 60x magnification. The commercial 
AECs were cultured in an eight chamber borosilicate coverglass system and stained with 
Dil-Ac-LDL, the bar is 10 µm. Images were taken with a Carl Zeiss Confocal (LSM 780 
Elyra S1 with SR-SIM super resolution platform) microscope. The concentration of the 
probe used was 10 µg/ml Dil-Ac-LDL. 
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4.2.4. Western blot analysis 
Cell cultures isolated using the collagenase method that were successfully identified as 
AECs were passaged until generation five. At this generation there were enough cells to 
prepare protein lysates. Protein lysates were prepared and the cytoplasmic fractions were 
used for western blot analysis to determine the presence of the eNOS enzyme and protein 
kinase B (PKB/Akt). The size of eNOS is 140 kDa and ubiquitously expressed by 
endothelial cells. eNOS is also activated by PKB/Akt which is upstream from eNOS in the 
insulin signalling pathway. PKB/Akt is a 60 kDa protein. A 7.5% SDS-PAGE gel was 
prepared and lysates from both commercial AECs and experimental cells were analysed. 
After separation, the proteins were transferred to a PVDF membrane as described in 
Materials and Methods and probed for total eNOS. As can be observed in figure 4.10 only 
the commercial AECs expressed total eNOS and not the experimental cells (Figure 4.10). 
Secondly, a 7.5% SDS-PAGE gel was prepared to detect PKB/Akt. Only lysates prepared 
from experimental cells were loaded and separated. The proteins were transferred to a 
PVDF membrane and probed for total PKB/Akt. All the lysates contained PKB/Akt in the 
cytoplasmic fractions (figure 4.11). 
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Figure 4.10: Total eNOS expression differences among the commercially purchased AECs 
and the experimental cells (endothelial cells isolated using the collagenase method). 
 
 
Figure 4.11: Total PKB-Akt expression in experimental cells isolated from the thoracic 
region of the rat aorta. 
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4.3. Summary and Discussion 
The growth rate of the cells isolated using the vascular ring method took 2 weeks to reach 
confluency before the cells could be passaged to the next generation. Due to this long 
incubation period and that almost none of the cells in culture were stained positively with 
Dil-Ac-LDL, it was concluded that this isolation procedure was unsuccessful. Therefore, 
the isolation of AECs using the vascular ring method was aborted. In comparison, the cells 
isolated using the collagenase method took one week to reach confluency before they 
could be passaged to the next generation. The morphology of the cell culture mirrored 
what is often observed in a known culture of AECs and the fact that most of cells isolated 
using this technique were stained positively with Dil-Ac-LDL indicated that the collagenase 
method used to isolate endothelial cells could be very useful in the future. But with this 
technique, it is not always possible to obtain a pure AEC culture as some cultures only had 
a 50% positive staining rate, which was not sufficient for cardiovascular studies which 
require the use of these cells. Furthermore, the fact that these cells did not express the 
eNOS enzyme is disconcerting as this is a major positive marker for endothelial cells  The 
results were also confusing, especially after morphological and Dil-Ac-LDL tests have 
identified these cell types as being endothelial cells. Thus to conclude, both the vascular 
ring method and the collagenase method were regarded as unsuccessful and would 
require  more optimization in the future than what time  allowed for this project.   
It was therefore decided to use commercially purchased AECs to complete the other 
remaining aims presented in the beginning.  
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Chapter 5: Flow Cytometry Results 
 
In Ataxia telangiectasia (AT) patients, the number one cause of death is cancer. Cancer is 
known as the uncontrollable cell division of abnormal cells often arising from mutations in 
its DNA.  
Vara et al. (2004) described the role of PKB/Akt in cancer cells as an inhibitor of apoptosis 
as it phosphorylates Bad and caspase-9 [Vara et al., 2004 and Hemmings and Restuccia, 
2012]. Li and Yang (2010) investigated the occurrence of apoptosis in MDA-MB-453 cells 
(breast cancer cells) and PC-3 cells (a prostate cancer cell line) when treated with the 
ATM inhibitor Ku-55933. What they observed was that under serum starvation conditions 
Ku-55933 had the ability to induce apoptosis in both cells lines [Li and Yang, 2010 and 
Yang et al., 2011]. Duan et al. (2011) studied the relationship between autophagy and 
apoptosis. What they observed in their data was that under glucose restrictions autophagy 
was induced and resulted in apoptosis in both ataxia telangiectasia (AT) skin fibroblasts 
and normal human skin fibroblasts [Duan et al., 2011]. In glucose restriction, the AMP/ATP 
ratio increases the activation of AMPK, an energy sensor, via LKB1 or ATM. Once 
activated, AMPK has the potential to activate p53, which mediates senescence, 
autophagy, apoptosis and growth arrest [Duan et al., 2011]. Yang et al, (2011) wrote that 
ATM-/- mice experience a decrease in pancreatic beta cell mass and an increase in 
pancreatic beta cell death as they age when compared to age matched controls [Yang et 
al., 2011]. This could be a possible reason for the development of diabetes often 
experienced by ATM patients. Furthermore when combined with rapamycin the two 
inhibitors (rapamycin and Ku-55933) together induces apoptosis and cancer cell 
proliferation better than on their own [Yang et al., 2011]. 
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Madamanchi et al. (2010) hypothesized in their literature review that apoptosis in ATM 
heterozygous (ATM+/-) ApoE null (ApoE-/-) macrophages are a result of mitochondrial 
DNA (mtDNA) damage [Madamanchi et al., 2010]. Furthermore, they concluded that 
macrophages that undergo apoptosis in the vascular wall contribute to plaque progression 
and instability in atherosclerosis [Madamanchi et al., 2010 and Li, H. et al., 2014]. Under 
physiological conditions, another contributor to apoptosis is reactive oxygen species 
(ROS). At basal conditions, ROS regulates many signalling pathways regarding 
maintaining vascular tone, inducing apoptosis and controlling cell growth and inflammatory 
responses [Li, H. et al., 2014]. When ROS exceeds the available antioxidants present in 
the body, oxidative stress arises and contributes to the onset of cardiovascular disease.   
As discussed in the literature review the ATM protein is a sensor and regulator of ROS 
within all cell types. Based on the literature, mtDNA damage, increased ROS and 
hyperglycaemia can all lead to the development of cardiovascular disease. Cardiovascular 
pathologies such as atherosclerosis are associated with a decrease in NO production 
which is a marker of endothelial dysfunction and a disruption in vascular homeostasis. 
Therefore, in this chapter the effects of the different stimulators (insulin) and inhibitors (Ku-
60019 and wortmannin) on AEC were determined by measuring the NO production and 
the viability of these cells after treatment. The protocol followed is as described in the 
methods chapter.  
5.1. AEC viability: Propidium iodide staining (necrosis)  
In figure 5.1 necrosis of AECs was measured with the use of propidium iodide staining. 
The AECs were previously treated with insulin, an ATM inhibitor Ku-60019 a combination 
of Ku-60019 and insulin, wortmannin and a combination of wortmannin with insulin. The 
aim of staining the cells with propidium iodide was to detect any cell death that may have 
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occurred due to treatment of these cells with one or a combination of the drugs used. Cell 
viability was measured using a density plot (figure 5.1). In the representative density plot 
shown in figure 5.1, the sub-population in the bottom left quadrant are the viable cells of 
the sample (88.8% of the total population were viable cells in this particular sample) and 
the sub-population in the bottom right quadrant are the non-viable necrotic cells (10% of 
the total cell population).  10 nM insulin, 3 µM Ku-60019 and 100 nM wortmannin had no 
effect on the necrosis, therefore on cell viability, of the AECs (figure 5.2).  
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Figure 5.1: Density plot used to determine the percentage of viable and non-viable cells in 
a total AECs population. The Y-axis represents propidium iodide fluorescence. The bottom 
left quadrant contains the viable (non-propidium iodide staining) cells (88.8% of the total 
AEC population) and the bottom right quadrant contains the non-viable, propidium iodide 
staining cells (10% of the total AEC population). 
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Figure 5.2: The effects of insulin, Ku-60019 and wortmannin on the development of 
necrosis (% cells staining positively with propidium iodide) in AECs. Ins = insulin; Ku = Ku-
60019; Wm = wortmannin. 
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5.2. NO-production 
The effects of 10 nM insulin, 3 µM Ku-60019, and 100 nM wortmannin on NO production 
was detected by measuring the fluorescence intensity of DAF-2/DA. 3 µM Ku-60019 
significantly increased the amount of NO produced compared to the vehicle (DMSO), (Ku 
3 µM: 1.326± 0.08906 vs. vehicle: 0.9981 ± 0.02958; p<0.05) (figure 5.3). 10 nM insulin 
produced significantly more NO than the wortmannin with insulin group (Ins 10 nM: 1.186 
± 0.04962 and Wm 100 nM with Ins 10 nM: 0.7964 ± 0.07332; p<0.01) (figure 5.3). 
Therefore, wortmannin inhibited the NO production induced by insulin but KU did not.  
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Figure 5.3: The effects of insulin, Ku-60019 and wortmannin on the production of NO (as 
determined by the arithmetic mean of the fluorescence intensity) in AECs. Approximately 
3-4 petri dishes were assigned to each treatment group. Ins = Insulin (10 nM); Ku = Ku-
60019 (3 µM); Wm = wortmannin (100 nM). 
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5.3. Summary and Discussion 
 
Based on the data insulin, Ku-60019 and wortmannin had no significant effect on necrosis 
in the AECs in comparison to the vehicle.  
The decrease observed in NO produced by the AECs in the wortmannin + insulin-groups 
compared to the insulin treated groups, indicates the inhibitory effect of wortmannin on the 
PI3-K signalling pathway. Furthermore, the data concerning the insulin treatment group 
and the wortmannin treatment groups confirms the need for eNOS enzyme activation at 
Ser1177 by PKB/Akt in response to insulin treatment. Surprisingly the inhibition of the ATM 
protein by its inhibitor Ku-60019 led to an increase in NO production. This aspect of the 
role of ATM in cardiovascular health and disease has not been researched before. One 
could speculate that the increased NO production seen in figure, 5.4 could be a result of  
an increase in eNOS expression when ATM is inhibited. According to Kobayashi, T. et al. 
(2007), treatment with insulin increases the expression of eNOS mRNA thereby increasing 
NO availability. Logically, with the increase in NO there is an increase in vasodilation 
which, is often observed at the onset of diabetes. As diabetes progresses the availability of 
NO decreases and the endothelium becomes dysfunctional [Kobayashi, T. et al., 2007]. 
Additionally, if NO is produced in the presence of superoxide anions the two react to 
produce peroxynitrite which is also a marker of oxidative stress and endothelial 
dysfunction. Furthermore, these observations could contribute to the insulin resistance, 
hyperglycaemia and diabetes observed in AT patients. 
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Chapter 6: Western blot analysis 
 
The glucose uptake pathway is controlled by both Protein kinase B (PKB/Akt) and AMP-
activated protein kinase (AMPK). According to Young et al. (2005) AMPK can be activated 
by oxidative stress and cardiovascular pathologies such as ischemia. Ischemia is 
characterized by the insufficient blood flow and delivery of oxygen and glucose to tissues 
such as the heart muscle [Young et al., 2005]. During ischemia, the ratio of AMP/ATP 
increases which is necessary to phosphorylate and activate the AMPK protein alpha 
subunit at Thr172. According to Li and Keaney (2010) AMPK phosphorylates eNOS to 
release NO resulting in increased vasodilation and decreased apoptosis in order to 
promote vascular homeostasis [Li and Keaney, 2010].  
In the AMPK signalling pathway, AMPK is activated by upstream proteins such as LKB1 
and Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), in response to a 
decrease in ATP, or by the pharmacological AMPK activator aminoimidazole carboxamide 
ribonucleotide (AICAR); [Fu et al., 2008]. According to Amatya et al, (2012) when DNA 
damage occurs the AMPK protein is activated in an LKB1 independent manner and in an 
ATM-dependent manner  by the DDR in human glioma cells (M059K and M059J), [Amatya 
et al., 2012].   
Once activated, AMPK directly mediates the translocation of glucose transporter 4 
(GLUT4) vesicles from the cytoplasm to the cell membrane. During metabolic stress 
AMPK-mediated glucose uptake is the primary method of maintaining glucose 
homeostasis when insulin is unable to mediate glucose uptake via the phosphatidylinositol 
3 kinase (PI3-K)-PKB/Akt signalling pathway [Young et al., 2005].  In contrast to AMPK-
mediated glucose uptake, the insulin PI3-K-PKB/Akt signalling pathway involves more 
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proteins in the glucose uptake pathway. As discussed previously in the first chapter, the 
proteins involved in the insulin mediated glucose uptake pathway include insulin receptor 
substrate-1 (IRS-1), PI3-K, phosphatidylinositol 4,5-biphosphate (PIP2) / 
phosphatidylinositol 3,4,5-trisphosphate (PIP3), Phosphatidylinositol dependent kinase 
(PDK1) ,PKB/Akt, Akt substrate, 160 kDa (AS160) and the GLUT4 protein itself. It was 
also found that the AS160 protein is not only a PKB/Akt substrate but an AMPK substrate 
as well. AS160 inhibition occurs by AMPK phosphorylation when mice muscle tissue 
(extensor digitorum longus) is treated with AICAR [Treebak et al., 2006].  
In this chapter the protein expression and phosphorylation of various proteins involved in 
the glucose uptake pathway were investigated by treating AECs with insulin, the ATM 
inhibitor Ku-60019 and PI3-K inhibitor wortmannin. The proteins of interest were: PI3-
K/P83, Phosphatase and tensin homolog (PTEN), PKB/Akt, AS160, Glycogen synthase 
kinase 3 beta (GSK3β), AMPK, Ataxia telangiectasia mutated (ATM), and eNOS. 
 
6.1. Insulin dose response experiments  
Insulin dose response experiments were completed as described in the methods chapter. 
AECs were treated with two different insulin concentrations (10 nM and 100 nM) to 
determine the lowest concentration that would result in the phosphorylation / activation of 
PKB/Akt at Ser473 and eNOS at Ser1177. For both PKB/Akt and eNOS, ß-tubulin was 
probed for to ensure there was equal loading.  
6.1.1. PKB/Akt 
In figure 6.1, it was observed that 100 nM insulin did not cause a significant increase in 
PKB/Akt phosphorylation compared to 10 nM insulin or the control group. Although not 
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statistically significant, there was an increase in the phosphorylation of PKB/Akt with the 
increase in insulin concentration (Figure 6.1, A) compared to the amount of total PKB/Akt 
protein expressed in the AECs (figure 6.1, B). The increase in PKB/Akt phosphorylation 
was confirmed by the phosphorylated over total ratios observed in figure 6.1 (C). For both 
the eNOS and the PKB/Akt proteins 10 nM insulin was enough to induce phosphorylation 
of these proteins compared to the control group (figure 6.1 and 6.2).  
 
6.1.2. eNOS 
In figure 6.2 representative western blots are shown to demonstrate eNOS 
phosphorylation at Ser1177 after insulin treatment (figure 6.2, A). 100 nM insulin did not 
increase the phosphorylation of eNOS compared to 10 nM insulin and the control group. 
10 nM insulin significantly decreased total eNOS expression compared to the control 
group (Control: 1.00 ± 0.03 vs. Insulin 10 nM: 0.72 ± 0.03 p=0.0004) (figure 6.2, B). 
100 nM insulin statistically increased the phosphorylation over total ratio compared to the 
control (Control: 1.00 ± 0.15 vs. Insulin 100 nM: 1.67 ± 0.14; p=0.0205) (figure 6.2, C).  
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Figure 6.1: PKB/Akt insulin dose response. (A) Phosphorylated PKB/Akt expressed in the 
cytosol of the AECs. (B) Total PKB/Akt protein expressed in the AECs. (C) The 
phosphorylated over total ratios, the amount of phosphorylated protein in the AECs 
exceeded that of the total PKB/Akt proteins in response to insulin. All data were corrected 
for β-tubulin. N=4 
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Figure 6.2: eNOS insulin dose response. (A) Phosphorylated eNOS proteins expressed in 
AECs. (B) Total eNOS protein present in AECs, contrary to the literature the addition of 
insulin appears to down-regulate the expression of eNOS in the 10 nM insulin group 
(p=0.004). (C) Phosphorylated over total ratios, 100 nM insulin had the highest ratio 
copared to the control (p=0.0205). All data were corrected for β-tubulin. 
 *: P<0.05 and ***: P<0.001. N=4 
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6.2. Stimulation and inhibition of the phosphatidylinositol-3 kinase (PI3-K) 
signalling pathway in aortic endothelial cells with emphasis on the ATM protein 
 
6.2.1. PI3-K/P85 
The P85 protein is one of the first proteins to be activated in response to insulin in the 
insulin-signalling pathway. In figure 6.3 (A) changes in phosphorylation of P85 were 
observed in response to 10 nM insulin and 3 µM Ku-60019 (Ku) compared to the vehicle.   
10 nM insulin significantly increased phosphorylation of P85 (1.365±0.078 vs. 0.99±0.003, 
p= 0.0033). This phosphorylation could be inhibited by 100 nM Wm (1.36±0.08 vs. 
0.93±.0.08, p=0.0073) (figure 6.3, A). 3  Ku however, could not inhibit the 
phosphorylation induced by 10 nM insulin (1.46±0.16 vs. 1.36±0.08, p=0.03). Surprisingly, 
Ku alone induced phosphorylation of P85 (1.36±0.08 vs. 0.99±0.003, p=0.0057). 10 nM 
Insulin was also able to increase the expression of P85 (1.26±0.06 vs. 0.99±0.003, 
p=0.0061). Unexpectedly, the expression of P85 was also increased by 100 nM Wm 
(2.06±0.39 vs. 0.99±0.003; p=0.0353) (figure 6.3, B). Calculating the phosphorylated to 
total ratio highlighted that 100 nM Wm will inhibit the phosphorylation induced by 10 nM 
insulin (1.10±0.12 vs 0.58±0.09; p=0.0116) (Fig 6.3 C).  
 
6.2.2. PTEN  
PTEN is a phosphatase protein, which dephosphorylates PIP3 or inhibits its 
phosphorylation by accepting a phosphate group from PIP3 [Mukherjee et al., 2013]. As 
shown in Fig 6.4 B, 10 nM insulin resulted in upregulation of PTEN from 0.99±0.003 to 
1.19±0.02, p<0.001. None of the other interventions changed either the phosphorylation or 
expression of PTEN. 
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Figure 6.3: P85 protein activation and inhibition (A) Phosphorylated P85, (B) total P85 and 
(C) the phosphorylated/total P85 ratio after the stimulation with insulin, Ku-60019 and 
wortmannin with or without insulin respectively. All data were corrected for β-tubulin. 
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Figure 6.4: PTEN protein activation and inhibition (A) Phosphorylated PTEN, (B) total 
PTEN and (C) the phosphorylated/total PTEN ratio after the stimulation with insulin, Ku-
60019 and wortmannin with or without insulin respectively. All data were corrected for β-
tubulin. 
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6.2.3. PKB/Akt 
PKB/Akt is a protein that is not only involved in the glucose uptake but also in 
angiogenesis, cell growth and proliferation and glycogen synthesis. PKB/Akt is 
phosphorylated in the presence of insulin. As can be observed in figure 6.5, 10 nM insulin 
significantly increased the phosphorylation of PKB/Akt compared to the vehicle group 
(1.34±0.14 vs. 0.99±0.003; p=0.0388) and this phosphorylation could be inhibited by 100 
nM wortmannin (1.34±0.14 vs. 0.89±0.04; p=0.0175) (figure 6.5, A).  10 nM insulin, 3 µM 
Ku and 100 nM Wm had no significant impact on the total protein expression of PKB/Akt 
(figure 6.5, B). However, a significant decrease was observed in the phosphorylated over 
total protein ratios (figure 6.5, C). AECs treated with 100 nM Wm had significantly less 
PKB/Akt phosphorylated over total ratios (0.73±0.11 vs. 0.99± 0.003; p=0.0468) and 100 
nM Wm decreased the phosphorylated over total ratio compared to 10 nM insulin (0.85± 
0.04 vs. 1.00±0.02; p=0.0166) (figure 6.5, C). 
 
6.2.4. GSK3β 
As mentioned GSK3β activity is inhibted by insulin by phosphorylation at Ser9 [Jensen at 
al., 2011]. 10 nM insulin significantly increased the phosphorylation of GSK3β  (2.12±0.02 
vs. 0.99±0.005; p=0.0003). Both 3 µM Ku (1.24±0.005 vs. 2.12±0.02; p=0.0005) and 
100 nM wortmannin (0.62±0.17 vs. 2.12±0.02; p=0.0128) significantly inhibited the insulin-
stimulated phosphorylation (figure 6.6, A).  Both 10 nM insulin and 100 nM Wm attenuated 
the expression of GSK3(vehicle: 0.99± 0.005 vs. 10 nM Ins: 0.88±0.005; p=0.0035  vs. 
100 nM: 0.79±0.03; p=0.0213) (figure 6.6, B). This effect was synergistic as a combination 
of Wm and Ins lowered the expression even more. (0.88±0.005 vs. 0.62±0.02; p=0.0037) 
(figure 6.6, B).  
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Calculating the ratio between phosphorylated and total protein also showed an effect of Ku 
on GSK3 A significant increase in the phosphorylated over total ratio was observed 
between the vehicle and the 3 µM Ku (0.99±0.005 vs. 1.46±0.06; p=0.0164) although no 
significant effect on either the phosphorylation or the expression was observed. The 
stimulatory effect of insulin as well as the inhibitory effect of Wm on the stimulation of 
insulin was clearly seen in this calculation: 10 nM Ins (2.42±0.02 vs. 0.99±0.005; 
p=0.0002) and 100 nM Wm with 10 nM insulin (1.02±0.30 vs. 2.42±0.02; p=0.0442) (figure 
6.6, C).  
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Figure 6.5: PKB/Akt protein activation and inhibition (A) Phosphorylated PKB/Akt, (B) total 
PKB/Akt and (C) the phosphorylated/total PKB/Akt ratio after the stimulation with insulin, 
Ku-60019 and wortmannin with or without insulin respectively. All data were corrected for 
β-tubulin. 
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Figure 6.6: GSK3β protein activation and inhibition (A) Phosphorylated GSK3β, (B) total 
GSK3β and (C) the phosphorylated/total GSK3β ratio after the stimulation with insulin, Ku-
60019 and wortmannin with or without insulin respectively. All data were corrected for β-
tubulin. 
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6.2.5. AMPK 
AMPK is the energy sensor in all tissue types and replenishes ATP when it has been 
depleted. AMPK is activated by an increase in AMP/ATP ratios and thus does not normally 
respond to insulin.  In figure 6.7 A,  the expected decrease in AMPK phosphorylation after 
stimulation with insulin was demonstrated (0.67±0.001 vs. 0.99±0.005; p=0.0002). The 
ATM inhibitor Ku, abolished this inhibition (0.95±0.029 vs. 0.67±0.001; p<0.05) but the  
PI3-K inhibitor Wm, unexpectedly, did not (0.83±0.006 vs. 0.99±0.005; p=0.0022) (figure 
6.7, A).  
10 nM insulin significantly attenuated the expression of total AMPK (0.90±0.004 vs. 0.99± 
0.005; p=0.0049) (figure 6.7, B).  
Calculating the ratio of phosphorylated to total protein therefore showed an increase in the 
ratio stimulated by insulin (1.33±0.03 vs. 0.99±0.005; p=0.0063, Fig 6.7, C). This 
calculation highlighted the effect of Ku both alone (0.58±0.02 vs. 0.99±0.005; p=0.0018) 
and by inhibiting the increase induced by insulin (1.33±0.03 vs. 0.59±0.12; p=0.026) (Fig 
6.7, C).  
 
6.2.6. ATM  
There were no significant differences in either the expression or the phosphorylation of 
ATM under the conditions examined (figure 6.8 A and B). However, calculating the ratio of 
phospho to total protein, showed an attenuation of this ratio in the presence of wortmannin 
(0.43±0.11 vs.  0.99±0.005; p=0.036) (Fig 6.8 C). 
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Figure 6.7: AMPK protein activation and inhibition (A) Phosphorylated AMPK, (B) total 
AMPK and (C) the phosphorylated/total AMPK ratio after the stimulation with insulin, Ku-
60019 and wortmannin with or without insulin respectively. All data were corrected for β-
tubulin. 
Stellenbosch University  https://scholar.sun.ac.za
120 
 
 
 
Figure 6.8: ATM protein activation and inhibition (A) Phosphorylated ATM, (B) total ATM 
and (C) the phosphorylated/total ATM ratio after the stimulation with insulin, Ku-60019 and 
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wortmannin with or without insulin respectively. In the absence ofβ-tubulin data were 
corrected using the stain-free technology provided by Bio-Rad (Bio-Rad, CA, USA) 
6.2.7. eNOS activation and inhibition 
As shown in figure 6.9 A, 100 nM wortmannin (Wm) significantly increased the 
phosphorylation of eNOS compared to the vehicle (2.75±0.35 vs. 0.99±0.01; p=0.0280) 
(6.9, A). There was a significant increase in the expression of total eNOS (figure 6.9, B) in 
AECs treated with a combination of 100 nM Wm and 10 nM insulin (Ins) compared to the 
10 nM insulin alone (2.83±0.47 vs. 0.94±0.23; p<0.05) (figure 6.9, B). Furthermore, the 
ratio of eNOS phosphorylation over the total eNOS protein between the various groups 
compared to the vehicle showed no significant differences (figure 6.9, C). 
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6.2.8. AS160 
The AS160 protein, a negative regulator of GLUT4, is believed to be inactivated by 
phosphorylation mediated by PKB/Akt. Insulin, which mediates AS160 inactivation did not 
significantly affect the phosphorylation of AS160 (figure 6.10, A). In figure 6.10 (A) there 
appears to be a discrepancy in the phosphorylation of the AS160 protein as increased 
phosphorylation is observed in the Ku, Ku + Ins, Wm and Wm + Ins treatment groups. 
100 nM Wm induced significantly more AS160 phosphorylation than 3 µM Ku (6.60±0.64 
vs. 1.0±0.05; P<0.01) (figure 6.10, A). 3 µM Ku + 10 nM Ins phosphorylated the AS160 
protein profoundly more than the 100 nM Wm + 10 nM Ins treatment (5.46±0.29 vs. 
1.03±1.03) (figure 6.10, A). In figure 6.10, B it can be observed that 100 nM wortmannin 
attenuated the expression of AS160 (0.81±0.01 vs. 1.00±0.01; p=0.0003). It was also 
observed that 100 nM Wm resulted in a significantly higher phosphorylated over total 
AS160 ratio compared to 3 µM Ku (7.54±1.24 vs 1.04±0.01; p=0.0345) (figure 6.10, C).  
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
123 
 
  
 
Figure 6.9: eNOS protein activation and inhibition. (A)Phosphorylated eNOS, (B) total 
eNOS and (C) the phosphorylated/total eNOS ratio after the stimulation with insulin, Ku-
60019 and wortmannin with or without insulin respectively. All data were corrected for β-
tubulin. 
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Figure 6.10: AS160 protein activation and inhibition (A) Phosphorylated as160, (B) total 
AS160 and (C) the phosphorylated/total AS160 ratio after the stimulation with insulin, Ku-
60019 and wortmannin with or without insulin respectively. All data were corrected for β-
tubulin. 
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6.3. Summary and Discussion  
PKB/Akt and AMPK kinase are two proteins both involved in NO production and glucose 
utilization by endothelial cells. The shared effector proteins are the eNOS enzyme and 
AS160 respectively.  Insulin is known to activate PKB/Akt via PI3-K but recently it has 
been postulated that ATM activation may be a prerequisite for PKB/Akt activation [Shiloh, 
2003 and Ching et al., 2013].  As discussed in the literature review, ATM activity may 
therefore be important in endothelial function or dysfunction.  This part of the current study 
utilized insulin as activator of these pathways and Ku-60019 as a specific ATM inhibitor.  
Wortmannin, well known for its ability to inhibit PI3-K, also has inhibitory effects on ATM at 
the concentrations used [Menotta et al., 2012; Yang and Kastan, 2000]. Measurement of 
the activity and expression of the proteins involved in these signalling pathways was used 
to try to dissect possible interactions. 
It was firstly demonstrated that stimulation of AEC’s with insulin resulted in both PKB/Akt 
and eNOS phosphorylation.  As it is known that 100 nM insulin is a pharmacological 
concentration that masks any synergistic effects, therefore10 nM insulin was used in this 
study.  Additionally, the concentration of insulin used in this study was not based on 
whether the 10 nM or 100 nM insulin concentrations caused the more significant increase 
in phosphorylated PKB/Akt and eNOS or in P/T PKB/Akt and eNOS ratios. But was the 
lowest concentration which could be used that caused and increase in the P/T ratio of both 
PKB/Akt and eNOS. 
Stimulating AEC’s with 10 nM insulin resulted in enhanced phosphorylation of the P85 
regulatory subunit of PI3-K that was indeed inhibited by wortmannin but not by Ku 
indicating that the effect of insulin on PI3-K is not mediated by ATM. However, Ku alone 
also enhanced phosphorylation of P85 indicating that the ATM protein may indeed interact 
with PI3-K by attenuating its activity under basal conditions [Viniegra et al., 2005].  
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The effect of insulin was accompanied by phosphorylation of PKB/Akt that was again 
inhibited by wortmannin, probably through the inhibition of PI3-K, but not by Ku, indicating 
again that the phosphorylation of PKB/Akt by insulin in endothelial cells is not mediated by 
ATM.  Still distal to PKB/Akt in the insulin-signalling pathway is the phosphorylation of 
GSK3measured as a read out of PKB/Akt activity.  Indeed, stimulation with 10 nM 
insulin also resulted in phosphorylation of GSK3 that was inhibited by wortmannin, but in 
this instance, also by Ku indicating that events downstream of PKB/Akt activation is 
affected by ATM.  The ratio of phospho/total GSK3 corroborates this as it was enhanced 
with insulin and attenuated by wortmannin but inhibition of ATM by Ku also enhanced this 
ratio. This may indicate that ATM has an inhibitory effect on the actions of activated 
PKB/Akt or it may also be that ATM normally regulates the expression of GSK3. It is 
known that the expression of GSK3 is regulated by PKB/Akt and vice versa through the 
activity of the Wnt signalling pathway [Wymann and Marone; 2005].  
As no effects of any intervention were seen on the phosphorylation of expression of PTEN, 
it was concluded that this phosphatase did not play a role in any of the effects 
investigated. However, our results showed a downregulation of PTEN expression induced 
by stimulation with 10 nM Insulin, corroborating previous reports that there exists a 
negative feedback mechanism on PKB/Akt activity through the PI3-K-PKB/Akt-mTOR 
pathway on the level of PTEN expression [Song et al., 2012 and Yu, Y. et al., 2011].  
The expected attenuation of phosphorylation of AMPK through inhibition by PKB/Akt was 
observed after stimulation with 10 nM insulin but because insulin also resulted in lower 
expression of AMPK, the phospho/total ratio was significantly enhanced.  Not only was the 
insulin-stimulated effect inhibited by inhibition of ATM but Ku alone also attenuated the 
phospho/total AMKP ratio confirming previous observations that ATM leads to activation of 
AMPK [Fu et al., 2008]. In addition, both wortmannin and Ku resulted in lower expression 
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of AMPK.  This effect may be because both inhibitors will inhibit the activity of ATM which 
is known to regulate the expression of AMPK through activation of P53 [Armata et al., 
2010].  
Stimulation of AEC’s with 10 nM insulin did not result in either phosphorylation or 
expression of ATM itself. However, the phospho/total ratio clearly showed that 100 nM 
wortmannin significantly attenuated the activation of ATM corroborating previous 
observations [Goodarzi and Lees-Miller, 2004.]  
10 nM insulin could in the end not stimulate the phosphorylation of eNOS significantly. A 
small effect of inhibition of both PI3-K and ATM with wortmannin was observed as this was 
manifested in the phospho/total ratio of activity.  
Conflicting results were also obtained at the level of phosphorylation of AS160 as, 
unexpectedly; wortmannin resulted in enhanced phosphorylation of AS160 as well as an 
increased phospho/total ratio.  It is possible that inhibition of the activity of PKB/Akt may 
enhance activity of AMPK as also shown in Fig 6.8A and that AMPK may then 
phosphorylate AS160. This result would then lead us to conclude that, in AEC’s; the AMPK 
pathway has a much stronger effect on AS160 activity than insulin via PKB/Akt. This is an 
observation that may be further investigated in future. An additional observation was that 
10 nM insulin was not enough to enhance AS160 phosphorylation but simultaneous 
inhibition of ATM enhanced the effect of insulin, now resulting in significant 
phosphorylation.  This again points to our previous conclusion that ATM has an inhibitory 
effect on the actions of PKB/Akt. In addition, we demonstrated that inhibition of PI3-K-
PKB/Akt attenuated AS160 expression in AECs. 
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Chapter 7: Discussion and Conclusion 
 
7.1. Literature review 
Ataxia telangiectasia (AT) is a well-characterized neurodegenerative disease and most of 
the nuclear functions of the ataxia telangiectasia mutated (ATM) protein has been 
investigated. The localization, role and function in various tissue types including neurons 
[Li et al., 2009 and Marinoglou, 2012] have been investigated extensively in AT patients 
and AT animal models.  
After the well-established function of ATM in the nucleus was concluded, researchers 
began to investigate the role of ATM in oxidative stress, associating oxidative stress with 
DNA damage, mitochondrial DNA damage and dysfunction as well as mitochondrial 
uncoupling [Madamanchi et al., 2010; Mookerjee et al., 2010 and Yu et al., 2013]. Many 
researchers have designated the function of ATM in the mitochondria to be that of an 
oxidative stress sensor that activates other proteins to alleviate and down regulate the 
detrimental effects of oxidative stress. 
In the current study, the role of ATM was investigated in AECs. Few studies have explored 
the function of the ATM protein in the cytosol in relation to glucose homeostasis, insulin 
sensitivity and diabetes among ATM null (ATM-/-), ATM heterozygous (ATM+/-) and ATM 
wild type (ATM+/+) tissue types. Often in tissue culture studies, disease states have to be 
simulated via in vitro induction by for example the addition of pharmacological inhibitors or 
inflammatory cytokines. Very little data is available on experiments completed in tissue 
culture whereby AECs were isolated from animal or human models with pathologies such 
as diet induced insulin resistance, diabetes or atherosclerosis. Therefore, the first aim of 
the present study was not only to isolate a pure aortic endothelial culture but also to 
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establish a method of isolating AECs that would consistently yield a pure culture of AECs. 
Flowing from this first aim, and depending on its success, we aimed to isolate AECs from 
diseased animals that are insulin resistant, diabetic; hyperglycaemic, obese and may have 
other symptoms of the metabolic syndrome. 
 
7.2. Aortic endothelial cell (AEC) isolation 
The data presented in chapter 4 indicates that our attempts to isolate AECs from healthy 
adult male Wistar rats were reasonably successful. A major advantage of setting up an in-
house endothelial cell isolation technique is the fact that the researcher can conduct 
experiments on true primary cells that have not been exposed to multiple passages and 
storage in liquid nitrogen for long periods before they are used. Another advantage is that 
of saving of time and money as it eliminates the necessity to buy commercially available 
endothelial cells and passage them into respective parental groups as described in figure 
3.3. However, most importantly, is the possibility of isolating these cells from diseased 
animals and age matched controls in order to observe physiological differences in protein 
expression and function of the AECs without inducing these pathologies in vitro. 
The limitations experienced in the present research project included the inconsistency in 
obtaining a pure AEC culture, particularly experienced with the vascular ring model. The 
biggest set-back, however, was the lack of detectable eNOS expression as observed in 
the western blots (figure 4.10). Furthermore, determining the non-endothelial cell types 
that contaminate the cell cultures has proven to be difficult because often smooth muscle 
cells, fibroblasts and endothelial cells possess a few of the same protein markers making 
the search for anti-fibroblast or anti-smooth muscle cell specific antibodies even harder. 
According to Azuma et al. (2009) thoracic AECs both in vitro and in vivo have the potential 
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to transdifferentiate into smooth muscle cells and that some of the endothelial cells both in 
the aorta or after isolation by means of enzyme digestion possess both endothelial cell 
markers and smooth muscle cell markers [Azuma et al., 2009].  Unfortunately, we were 
therefore unable to meet all the strict criteria we had set for ourselves, and the lack of 
detectable expression of the eNOS protein resulted in the decision to rather conduct the 
experiments in the second part of the study on commercially purchased AECs. 
 
7.3. Nitric oxide production and AEC viability in response to insulin, Ku-60019 and 
wortmannin 
As observed in figure 5.3 there was a significant increase in NO production when the ATM 
protein was inhibited by Ku-60019. The beneficial impact of increased NO production 
(especially eNOS-derived) includes maintaining vascular homeostasis, promoting 
angiogenesis, initiating DNA repair by activating p53 [Goodman et al., 2004], inhibiting 
smooth muscle cell proliferation and many other functions in the respiratory system, 
inflammation responses and nervous system [Mian et al., 2013]. Conversely, high 
(excessive) NO concentrations can be harmful as it readily reacts with superoxide anions 
to generate peroxynitrite. According to Munoz et al. (2009), reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) can exert both protective and harmful effects. 
Examples of these include cell death due to high concentrations of ROS, preconditioning 
by the heart towards ischemic injury or “sudden death” in response to ischemia-
reperfusion [Munoz et al., 2009]. As observed in figure 5.2 the effects of Ku-60019, 
wortmannin and insulin treatment did not significantly affect the viability of the AECs. As 
the AECs were only exposed to Ku-60019 and wortmannin for 30 min and insulin for 
15 min it is unknown, what prolonged exposure to these inhibitors or insulin will do to the 
viability of the AECs or their production of NO in a time dependent manner. 
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The increase in NO production observed by the inhibition of ATM as is in chapter 5 may 
not be a result of eNOS activation alone, as according to the western blot data (figure 6.9) 
inhibition of ATM by Ku-60019 did not affect the phosphorylation and activity of the eNOS 
protein. This could suggest that the inhibition of the ATM protein in the AECs may lead to 
the activation of one of the other NOS isoforms (iNOS or nNOS). One of the unexplained 
results in our study is that inhibition of ATM with Ku resulted in a significant increase in NO 
production. As this is totally contrary to what we expected, this observation will be further 
investigated because it indicates a significant regulatory role for ATM in AECs and 
possibly its vasoconstrictory effects. 
 
7.4. The relationship between ATM and eNOS function in the insulin-signalling 
pathway. 
We have demonstrated for the first time, a relationship between endothelial ATM protein 
kinase and the generation of NO. The study was expanded to investigate central proteins 
that may be involved in this reaction. The signalling pathways involved in NO production 
and glucose utilization form a network of interrelationships. Central to both pathways is the 
activity of 2 protein kinases, PKB/Akt and AMPK.  Both these kinases are known to 
phosphorylate the eNOS enzyme to produce NO on the one hand and AS160 to induce 
GLUT 4 translocation and glucose uptake on the other hand. Activation of the ATM protein 
is postulated to be a prerequisite for PKB/Akt activation and it may result in activation of 
AMPK.  
 
A second important observation was that inhibition of ATM significantly enhanced 
phosphorylation of the p85 regulatory subunit of PI3-K. This would imply that ATM 
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normally has an inhibitory effect on p85 phosphorylation and therefore PI3-K activation. 
We base this assumption on previous publications showing that Ku does not inhibit PI3-K 
[Vecchio et al., 2014]. This again indicates that ATM has a hitherto unexplored regulatory 
role in endothelial function.  
 
7.5. Conclusion 
In the present study it has been established that the AECs express the ATM protein. 
Unexpectedly, ATM inhibition by Ku-60019 increased NO production within the AECs 
without significantly increasing the phosphorylation of eNOS in the PI3-K signalling 
pathway. In addition to this, inhibition of the ATM protein did not result in a decrease in 
PKB/Akt phosphorylation indicating that the interaction between PKB/Akt and eNOS within 
the PI3-K signalling pathway is quite complex and requires further investigation into the 
exact mechanisms by which ATM regulates PKB/Akt and eNOS. 
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